1
|
Yadav SK, Verma D, Yadav U, Kalkal A, Priyadarshini N, Kumar A, Mahato K. Point-of-Care Devices for Viral Detection: COVID-19 Pandemic and Beyond. MICROMACHINES 2023; 14:1744. [PMID: 37763907 PMCID: PMC10535693 DOI: 10.3390/mi14091744] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/17/2023] [Revised: 08/29/2023] [Accepted: 08/30/2023] [Indexed: 09/29/2023]
Abstract
The pandemic of COVID-19 and its widespread transmission have made us realize the importance of early, quick diagnostic tests for facilitating effective cure and management. The primary obstacles encountered were accurately distinguishing COVID-19 from other illnesses including the flu, common cold, etc. While the polymerase chain reaction technique is a robust technique for the determination of SARS-CoV-2 in patients of COVID-19, there arises a high demand for affordable, quick, user-friendly, and precise point-of-care (POC) diagnostic in therapeutic settings. The necessity for available tests with rapid outcomes spurred the advancement of POC tests that are characterized by speed, automation, and high precision and accuracy. Paper-based POC devices have gained increasing interest in recent years because of rapid, low-cost detection without requiring external instruments. At present, microfluidic paper-based analysis devices have garnered public attention and accelerated the development of such POCT for efficient multistep assays. In the current review, our focus will be on the fabrication of detection modules for SARS-CoV-2. Here, we have included a discussion on various strategies for the detection of viral moieties. The compilation of these strategies would offer comprehensive insight into the detection of the causative agent preparedness for future pandemics. We also provide a descriptive outline for paper-based diagnostic platforms, involving the determination mechanisms, as well as a commercial kit for COVID-19 as well as their outlook.
Collapse
Affiliation(s)
- Sumit K. Yadav
- Department of Biotechnology, Vinoba Bhave University, Hazaribagh 825301, Jharkhand, India
| | - Damini Verma
- Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee 247667, Uttarakhand, India
| | - Ujala Yadav
- Department of Life Sciences, Central University of Jharkhand, Ranchi 835205, Jharkhand, India
| | - Ashish Kalkal
- Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee 247667, Uttarakhand, India
| | - Nivedita Priyadarshini
- Department of Zoology, DAV PG College Siwan, Jai Prakash University, Chhapra 841226, Bihar, India
| | - Ashutosh Kumar
- Department of Electrical Engineering, University of Notre Dame, Notre Dame, IN 46637, USA
| | - Kuldeep Mahato
- Department of Nanoengineering, University of California San Diego, 9500 Gilman Dr, La Jolla, San Diego, CA 92093, USA
| |
Collapse
|
2
|
Hussein HA, Kandeil A, Gomaa M, Hassan RYA. Double-antibody-based nano-biosensing system for the onsite monitoring of SARS-CoV-2 variants. MICROSYSTEMS & NANOENGINEERING 2023; 9:105. [PMID: 37614970 PMCID: PMC10442362 DOI: 10.1038/s41378-023-00578-0] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/14/2022] [Revised: 07/10/2023] [Accepted: 07/13/2023] [Indexed: 08/25/2023]
Abstract
The fast and reliable diagnosis of COVID-19 is the foremost priority for promoting public health interventions. Therefore, double-antibody-based immunobiosensor chips were designed, constructed, and exploited for clinical diagnosis. Gold nanoparticles/tungsten oxide/carbon nanotubes (AuNPs/WO3/CNTs) were used as the active working sensor surface to support the chemical immobilization of a mixture of SARS-CoV-2 antibodies (anti-RBD-S and anti-RBD-S-anti-Llama monoclonal antibodies). The morphology and chemical functionalization of the fabricated disposable immunochips was characterized using scanning electron microscopy (SEM), Fourier transform infrared (FTIR) spectroscopy, cyclic voltammetry (CV), and electrochemical impedance spectroscopy (EIS). After full assay optimization, the immunobiosensor showed a high sensitivity to detect SARS-CoV-2-S protein with limits of detection and quantification of 1.8 and 5.6 pg/mL, respectively. On the other hand, for the SARS-CoV-2 whole virus particle analysis, the detection and quantification limits were determined to be 5.7 and 17 pg/mL, respectively. The biosensor showed a highly selective response toward SARS-CoV-2, even in the presence of influenza, nontargeting human coronaviruses, and Middle East respiratory syndrome coronavirus (MERS-CoV). The immunochips exhibited distinct responses toward the variants of concern: B.1>C.36.3>Omicron> Delta> Alpha coronavirus variants. For biosensor validation, twenty-nine clinical specimens were analyzed, and the impedimetric responses were positively detected for two Delta samples, eighteen Omicron samples, and six B.1-type samples in addition to three negative samples. Eventually, the immunobiosensor was fabricated in the form of ready-to-use chips capable of sensitive detection of virus variants, especially variants of concern (VOC) and interest, in a specimen within 15 min. The chips provided instantaneous detection with the direct application of clinical samples and are considered a point-of-care device that could be used in public places and hot spots.
Collapse
Affiliation(s)
- Heba A. Hussein
- Virology Department, Animal Health Research Institute (AHRI), Agricultural Research Center (ARC), Giza, 12619 Egypt
- Biosensors Research Laboratory, Zewail City of Science and Technology, 6th October City, Giza, 12578 Egypt
| | - Ahmed Kandeil
- Center of Scientific Excellence for Influenza Viruses, Environmental Research Division, National Research Centre, Giza, 12622 Egypt
| | - Mokhtar Gomaa
- Center of Scientific Excellence for Influenza Viruses, Environmental Research Division, National Research Centre, Giza, 12622 Egypt
| | - Rabeay Y. A. Hassan
- Biosensors Research Laboratory, Zewail City of Science and Technology, 6th October City, Giza, 12578 Egypt
- Nanoscience Program, University of Science and Technology (UST), Zewail City of Science and Technology, Giza, 12578 Egypt
| |
Collapse
|
3
|
Moroni-Zentgraf P, Keller C, Eschenfelder CC, Walter Müller H, Sigmund R, Galeana-Cadena D, Márquez-García JE, Moncada-Morales A, Zúñiga JA. Salivette® Cortisol versus oropharyngeal swabbing for the detection of SARS-CoV-2 infection. Expert Rev Mol Diagn 2023; 23:1011-1014. [PMID: 37724431 DOI: 10.1080/14737159.2023.2260308] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2023] [Accepted: 09/10/2023] [Indexed: 09/20/2023]
Abstract
BACKGROUND Detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by naso/oropharyngeal swabbing may expose health-care workers to the virus and is technically challenging. The Salivette® is an alternative saliva-collection device with an oral cotton swab containing citric acid to stimulate saliva production, which may have an unpleasant taste. We present a pilot study comparing the Salivette® Cortisol (SC), which uses a synthetic swab without citric acid, against oropharyngeal swabbing for the detection of SARS-CoV-2 by reverse transcription quantitative polymerase chain reaction (RT-qPCR). RESEARCH DESIGN AND METHODS Symptomatic SARS-CoV-2-positive patients were sampled at various timepoints. The number of patients positive/negative for SARS-CoV-2 in oropharyngeal swab and SC samples and the percentage of patients testing true positive/true negative for SARS-CoV-2 from SC samples were determined. Positivity was defined by RT-qPCR amplification of 2/3 target SARS-CoV-2 N, ORF1, and S gene sequences. RESULTS SC demonstrated 100% specificity, 52.2% sensitivity, and positive correlation with oropharyngeal swabbing for the detection of the SARS-CoV-2 S gene. In later-stage disease, lower viral load was observed in SC samples compared with oropharyngeal swabs. CONCLUSIONS The SC may be an alternative for SARS-CoV-2 detection where naso/oropharyngeal swabbing is not feasible/available. This technique also confirms observations that the detection of SARS-CoV-2 in the upper airway may vary due to viral load over the disease course. TRIAL REGISTRATION NCT04599959.
Collapse
Affiliation(s)
- Petra Moroni-Zentgraf
- Human Pharma Medicine, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany
| | - Christoph Keller
- HP Country Pharmacovigilance, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany
| | | | - Hanns Walter Müller
- Non-Clinical Statistics, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany
| | - Ralf Sigmund
- Biostatistics and Data Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany
| | - David Galeana-Cadena
- Laboratory of Immunobiology and Genetics, Instituto Nacional de Enfermedades Respiratorias Ismaesl Cosío Villegas, Mexico City, Mexico
| | - José Eduardo Márquez-García
- Laboratory of Immunobiology and Genetics, Instituto Nacional de Enfermedades Respiratorias Ismaesl Cosío Villegas, Mexico City, Mexico
| | - Angélica Moncada-Morales
- Laboratory of Immunobiology and Genetics, Instituto Nacional de Enfermedades Respiratorias Ismaesl Cosío Villegas, Mexico City, Mexico
| | - Joaquin A Zúñiga
- Laboratory of Immunobiology and Genetics, Instituto Nacional de Enfermedades Respiratorias Ismaesl Cosío Villegas, Mexico City, Mexico
- National Institute of Respiratory Diseases-Mexico (INER), Tecnologico de Monterrey, Escuale ade Medicina y Ciencias de las Salud, Monterrey, Mexico
| |
Collapse
|
4
|
Detection of live SARS-CoV-2 virus and its variants by specially designed SERS-active substrates and spectroscopic analyses. Anal Chim Acta 2023; 1256:341151. [PMID: 37037632 PMCID: PMC10060322 DOI: 10.1016/j.aca.2023.341151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2022] [Revised: 03/07/2023] [Accepted: 03/26/2023] [Indexed: 04/05/2023]
Abstract
A method using label-free surface enhanced Raman spectroscopy (SERS) based on substrate design is provided for an early detection and differentiation of spike glycoprotein mutation sites in live SARS-CoV-2 variants. Two SERS-active substrates, Au nanocavities (Au NCs) and Au NPs on porous ZrO2 (Au NPs/pZrO2), were used to identify specific peaks of A.3, Alpha, and Delta variants at different concentrations and demonstrated the ability to provide their SERS spectra with detection limits of 0.1–1.0% (or 104−5 copies/mL). Variant identification can be achieved by cross-examining reference spectra and analyzing the substrate-analyte relationship between the suitability of the analyte upon the hotspot(s) formed at high concentrations and the effective detection distance at low concentrations. Mutation sites on the S1 chain of the spike glycoprotein for each variant may be related and distinguishable. This method does not require sample preprocessing and therefore allows for fast screening, which is of high value for more comprehensive and specific studies to distinguish upcoming variants.
Collapse
|
5
|
Hussein HA, Hanora A, Solyman SM, Hassan RYA. Designing and fabrication of electrochemical nano-biosensor for the fast detection of SARS-CoV-2-RNA. Sci Rep 2023; 13:5139. [PMID: 36991070 PMCID: PMC10054215 DOI: 10.1038/s41598-023-32168-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2023] [Accepted: 03/23/2023] [Indexed: 03/31/2023] Open
Abstract
SARS-CoV-2 caused a global panic among populations. Rapid diagnostic procedures for the virus are crucial for disease control. Thus, the designed signature probe from a highly conserved region of the virus was chemically immobilized onto the nanostructured-AuNPs/WO3-screen printed electrodes. Different concentrations of the matched oligonucleotides were spiked to test the specificity of the hybridization affinity whereas the electrochemical impedance spectroscopy was used for tracking the electrochemical performance. After a full assay optimization, limits of detection and quantification were calculated based on linear regression and were valued at 298 and 994 fM, respectively. Further, the high performance of the fabricated RNA-sensor chips was confirmed after testing the interference status in the presence of the mismatched oligos in one nucleotide and completely one. Worthy to mention that the single-stranded matched oligos can be hybridized to the immobilized probe in 5 min at room temperature. The designed disposable sensor chips are capable of detecting the virus genome directly. Therefore, the chips are a rapid tool for SARS-CoV-2 detection.
Collapse
Affiliation(s)
- Heba A Hussein
- Virology Department, Animal Health Research Institute (AHRI), Agricultural Research Center (ARC), Giza, 12619, Egypt.
| | - Amro Hanora
- Department of Microbiology and Immunology, College of Pharmacy, Suez Canal University, Ismailia, Egypt
| | - Samar M Solyman
- Department of Microbiology and Immunology, College of Pharmacy, Suez Canal University, Ismailia, Egypt
| | - Rabeay Y A Hassan
- Biosensors Research Laboratory, Zewail City of Science and Technology, 6Th October City, Giza, 12578, Egypt.
| |
Collapse
|
6
|
Bacteriophage-based nano-biosensors for the fast impedimetric determination of pathogens in food samples. Sci Rep 2023; 13:3498. [PMID: 36859463 PMCID: PMC9977096 DOI: 10.1038/s41598-023-30520-3] [Citation(s) in RCA: 9] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2022] [Accepted: 02/24/2023] [Indexed: 03/03/2023] Open
Abstract
The early and rapid detection of pathogenic microorganisms is of critical importance in addressing serious public health issues. Here, a new bacteriophage-based nano-biosensor was constructed and the electrochemical impedimetric method was fully optimized and applied for the quantitative detection of Escherichia coli O157:H7 in food samples. The impact of using a nanocomposite consisting of gold nanoparticles (AuNPs), multi-walled carbon nanotubes (MWCNTs), and tungsten oxide nanostructures (WO3) on the electrochemical performance of disposable screen printed electrodes was identified using the cyclic voltammetry and electrochemical impedance spectroscopy. The use nanomaterials enabled high capturing sensitivity against the targeting bacterial host cells with the limit of detection of 3.0 CFU/ml. Moreover, selectivity of the covalently immobilized active phage was tested against several non-targeting bacterial strains, where a high specificity was achieved. Thus, the targeting foodborne pathogen was successfully detected in food samples with high specificity, and the sensor provided an excellent recovery rate ranging from 90.0 to 108%. Accordingly, the newly developed phage-biosensor is recommended as a disposable label-free impedimetric biosensor for the quick and real-time monitoring of food quality.
Collapse
|
7
|
Kim K, Lee WG. Portable, Automated and Deep-Learning-Enabled Microscopy for Smartphone-Tethered Optical Platform Towards Remote Homecare Diagnostics: A Review. SMALL METHODS 2023; 7:e2200979. [PMID: 36420919 DOI: 10.1002/smtd.202200979] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/27/2022] [Revised: 10/18/2022] [Indexed: 06/16/2023]
Abstract
Globally new pandemic diseases induce urgent demands for portable diagnostic systems to prevent and control infectious diseases. Smartphone-based portable diagnostic devices are significantly efficient tools to user-friendly connect personalized health conditions and collect valuable optical information for rapid diagnosis and biomedical research through at-home screening. Deep learning algorithms for portable microscopes also help to enhance diagnostic accuracy by reducing the imaging resolution gap between benchtop and portable microscopes. This review highlighted recent progress and continued efforts in a smartphone-tethered optical platform through portable, automated, and deep-learning-enabled microscopy for personalized diagnostics and remote monitoring. In detail, the optical platforms through smartphone-based microscopes and lens-free holographic microscopy are introduced, and deep learning-based portable microscopic imaging is explained to improve the image resolution and accuracy of diagnostics. The challenges and prospects of portable optical systems with microfluidic channels and a compact microscope to screen COVID-19 in the current pandemic are also discussed. It has been believed that this review offers a novel guide for rapid diagnosis, biomedical imaging, and digital healthcare with low cost and portability.
Collapse
Affiliation(s)
- Kisoo Kim
- Intelligent Optical Module Research Center, Korea Photonics Technology Institute (KOPTI), Buk-gu, Gwangju, 61007, Republic of Korea
| | - Won Gu Lee
- Department of Mechanical Engineering, Kyung Hee University, Yongin, 17104, Republic of Korea
| |
Collapse
|
8
|
Byakodi M, Shrikrishna NS, Sharma R, Bhansali S, Mishra Y, Kaushik A, Gandhi S. Emerging 0D, 1D, 2D, and 3D nanostructures for efficient point-of-care biosensing. BIOSENSORS & BIOELECTRONICS: X 2022; 12:100284. [PMID: 36448023 PMCID: PMC9691282 DOI: 10.1016/j.biosx.2022.100284] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/23/2022] [Revised: 11/14/2022] [Accepted: 11/16/2022] [Indexed: 04/12/2023]
Abstract
The recent COVID-19 infection outbreak has raised the demand for rapid, highly sensitive POC biosensing technology for intelligent health and wellness. In this direction, efforts are being made to explore high-performance nano-systems for developing novel sensing technologies capable of functioning at point-of-care (POC) applications for quick diagnosis, data acquisition, and disease management. A combination of nanostructures [i.e., 0D (nanoparticles & quantum dots), 1D (nanorods, nanofibers, nanopillars, & nanowires), 2D (nanosheets, nanoplates, nanopores) & 3D nanomaterials (nanocomposites and complex hierarchical structures)], biosensing prototype, and micro-electronics makes biosensing suitable for early diagnosis, detection & prevention of life-threatening diseases. However, a knowledge gap associated with the potential of 0D, 1D, 2D, and 3D nanostructures for the design and development of efficient POC sensing is yet to be explored carefully and critically. With this focus, this review highlights the latest engineered 0D, 1D, 2D, and 3D nanomaterials for developing next-generation miniaturized, portable POC biosensors development to achieve high sensitivity with potential integration with the internet of medical things (IoMT, for miniaturization and data collection, security, and sharing), artificial intelligence (AI, for desired analytics), etc. for better diagnosis and disease management at the personalized level.
Collapse
Affiliation(s)
- Manisha Byakodi
- DBT-National Institute of Animal Biotechnology (NIAB), Hyderabad, 500032, Telangana, India
| | - Narlawar Sagar Shrikrishna
- DBT-National Institute of Animal Biotechnology (NIAB), Hyderabad, 500032, Telangana, India
- DBT-Regional Centre for Biotechnology (RCB), Faridabad, 121001, Haryana (NCR Delhi), India
| | - Riya Sharma
- DBT-National Institute of Animal Biotechnology (NIAB), Hyderabad, 500032, Telangana, India
| | - Shekhar Bhansali
- Department of Electrical and Computer Engineering, Florida International University, Miami, FL, 33174, USA
| | - Yogendra Mishra
- Mads Clausen Institute, NanoSYD, University of Southern Denmark, Alsion 2, 6400, Sønderborg, Denmark
| | - Ajeet Kaushik
- NanoBioTech Laboratory, Department of Environmental Engineering, Florida Polytechnic University, Lakeland, FL, USA
| | - Sonu Gandhi
- DBT-National Institute of Animal Biotechnology (NIAB), Hyderabad, 500032, Telangana, India
- DBT-Regional Centre for Biotechnology (RCB), Faridabad, 121001, Haryana (NCR Delhi), India
| |
Collapse
|
9
|
Babadi AA, Rahmati S, Fakhlaei R, Heidari R, Baradaran S, Akbariqomi M, Wang S, Tavoosidana G, Doherty W, Ostrikov K. SARS-CoV-2 detection by targeting four loci of viral genome using graphene oxide and gold nanoparticle DNA biosensor. Sci Rep 2022; 12:19416. [PMID: 36371566 PMCID: PMC9653406 DOI: 10.1038/s41598-022-23996-y] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2022] [Accepted: 11/08/2022] [Indexed: 11/13/2022] Open
Abstract
The current COVID-19 pandemic outbreak poses a serious threat to public health, demonstrating the critical need for the development of effective and reproducible detection tests. Since the RT-qPCR primers are highly specific and can only be designed based on the known sequence, mutation sensitivity is its limitation. Moreover, the mutations in the severe acute respiratory syndrome β-coronavirus (SARS-CoV-2) genome led to new highly transmissible variants such as Delta and Omicron variants. In the case of mutation, RT-qPCR primers cannot recognize and attach to the target sequence. This research presents an accurate dual-platform DNA biosensor based on the colorimetric assay of gold nanoparticles and the surface-enhanced Raman scattering (SERS) technique. It simultaneously targets four different regions of the viral genome for detection of SARS-CoV-2 and its new variants prior to any sequencing. Hence, in the case of mutation in one of the target sequences, the other three probes could detect the SARS-CoV-2 genome. The method is based on visible biosensor color shift and a locally enhanced electromagnetic field and significantly amplified SERS signal due to the proximity of Sulfo-Cyanine 3 (Cy3) and AuNPs intensity peak at 1468 cm-1. The dual-platform DNA/GO/AuNP biosensor exhibits high sensitivity toward the viral genome with a LOD of 0.16 ng/µL. This is a safe point-of-care, naked-eye, equipment-free, and rapid (10 min) detection biosensor for diagnosing COVID-19 cases at home using a nasopharyngeal sample.
Collapse
Affiliation(s)
- Arman Amani Babadi
- grid.440785.a0000 0001 0743 511XSchool of Energy and Power Engineering, Jiangsu University, Zhenjiang, 212013 Jiangsu China ,grid.411705.60000 0001 0166 0922Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, 55469-14177 Iran
| | - Shahrooz Rahmati
- grid.1024.70000000089150953School of Chemistry and Physics, Queensland University of Technology (QUT), Brisbane, 4000 Australia ,grid.1024.70000000089150953Centre for Agriculture and the Bioeconomy, Queensland University of Technology (QUT), Brisbane, 4000 Australia ,grid.1024.70000000089150953Centre for Materials Science, Queensland University of Technology (QUT), 2 George Street, Brisbane, 4000 Australia ,grid.1024.70000000089150953Centre for Biomedical Technologies, Queensland University of Technology (QUT), 2 George Street, Brisbane, 4000 Australia
| | - Rafieh Fakhlaei
- grid.11142.370000 0001 2231 800XFood Safety and Food Integrity (FOSFI), Institute of Tropical Agriculture and Food Security, Universiti Putra Malaysia, 43400 Serdang, Selangor Malaysia
| | - Reza Heidari
- grid.411259.a0000 0000 9286 0323Research Center for Cancer Screening and Epidemiology, AJA University of Medical Sciences, Tehran, 14117-18541 Iran
| | - Saeid Baradaran
- grid.411368.90000 0004 0611 6995New Technologies Research Center, Amirkabir University of Technology, Tehran, 15916-34311 Iran
| | - Mostafa Akbariqomi
- grid.411521.20000 0000 9975 294XApplied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, 14359-16471 Iran
| | - Shuang Wang
- grid.440785.a0000 0001 0743 511XSchool of Energy and Power Engineering, Jiangsu University, Zhenjiang, 212013 Jiangsu China
| | - Gholamreza Tavoosidana
- grid.411705.60000 0001 0166 0922Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, 55469-14177 Iran
| | - William Doherty
- grid.1024.70000000089150953Centre for Agriculture and the Bioeconomy, Queensland University of Technology (QUT), Brisbane, 4000 Australia
| | - Kostya Ostrikov
- grid.1024.70000000089150953School of Chemistry and Physics, Queensland University of Technology (QUT), Brisbane, 4000 Australia ,grid.1024.70000000089150953Centre for Agriculture and the Bioeconomy, Queensland University of Technology (QUT), Brisbane, 4000 Australia ,grid.1024.70000000089150953Centre for Materials Science, Queensland University of Technology (QUT), 2 George Street, Brisbane, 4000 Australia ,grid.1024.70000000089150953Centre for Biomedical Technologies, Queensland University of Technology (QUT), 2 George Street, Brisbane, 4000 Australia
| |
Collapse
|
10
|
Hassan RYA. Advances in Electrochemical Nano-Biosensors for Biomedical and Environmental Applications: From Current Work to Future Perspectives. SENSORS (BASEL, SWITZERLAND) 2022; 22:s22197539. [PMID: 36236638 PMCID: PMC9573286 DOI: 10.3390/s22197539] [Citation(s) in RCA: 20] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/30/2022] [Revised: 09/26/2022] [Accepted: 09/30/2022] [Indexed: 05/17/2023]
Abstract
Modern life quality is strongly supported by the advances made in biosensors, which has been attributed to their crucial and viable contribution in point-of-care (POC) technology developments. POC devices are exploited for the fast tracing of disease progression, rapid analysis of water, and food quality assessment. Blood glucose meters, home pregnancy strips, and COVID-19 rapid tests all represent common examples of successful biosensors. Biosensors can provide great specificity due to the incorporation of selective bio-recognition elements and portability at significantly reduced costs. Electrochemical biosensor platforms are one of the most advantageous of these platforms because they offer many merits, such as being cheap, selective, specific, rapid, and portable. Furthermore, they can be incorporated into smartphones and various analytical approaches in order to increase their sensitivity and many other properties. As a very broad and interdisciplinary area of research and development, biosensors include all disciplines and backgrounds from materials science, chemistry, physics, medicine, microbiology/biology, and engineering. Accordingly, in this state-of-the-art article, historical background alongside the long journey of biosensing construction and development, starting from the Clark oxygen electrode until reaching highly advanced wearable stretchable biosensing devices, are discussed. Consequently, selected examples among the miscellaneous applications of nanobiosensors (such as microbial detection, cancer diagnosis, toxicity analysis, food quality-control assurance, point of care, and health prognosis) are described. Eventually, future perspectives for intelligent biosensor commercialization and exploitation in real-life that is going to be supported by machine learning and artificial intelligence (AI) are stated.
Collapse
Affiliation(s)
- Rabeay Y. A. Hassan
- Applied Organic Chemistry Department, National Research Centre Dokki, Cairo 12622, Egypt; ; Tel.: +20-11292-16152
- Nanoscience Program, University of Science and Technology (UST), Zewail City of Science and Technology, Giza 12578, Egypt
| |
Collapse
|
11
|
Guerrero-Esteban T, Gutiérrez-Sánchez C, Villa-Manso AM, Revenga-Parra M, Pariente F, Lorenzo E. Sensitive SARS-CoV-2 detection in wastewaters using a carbon nanodot-amplified electrochemiluminescence immunosensor. Talanta 2022; 247:123543. [PMID: 35594835 PMCID: PMC9101780 DOI: 10.1016/j.talanta.2022.123543] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2022] [Revised: 05/06/2022] [Accepted: 05/10/2022] [Indexed: 02/08/2023]
Abstract
Given the great utility that having fast, efficient and cost-effective methods for the detection of SARS-CoV-2 in wastewater can have in controlling the pandemic caused by this virus, the development of new dependable and specific SARS-CoV-2 coronavirus sensing devices to be applied to wastewater is essential to promote public health interventions. Therefore, herein we propose a new method to detect SARS-CoV-2 in wastewater based on a carbon nanodots-amplified electrochemiluminescence immunosensor for the determination of the SARS-CoV-2 Spike S1 protein. For the construction of the immunosensor, N-rich carbon nanodots have been synthetized with a double function: to contribute as amplifiers of the electrochemiluminescent signal in presence of [Ru(bpy)3]2+ and as antibody supports by providing functional groups capable of covalently interacting with the SARS-CoV-2 Spike S1 antibody. The proposed ECL immunosensor has demonstrated a high specificity in presence of other virus-related proteins and responded linearly to SARS-CoV-2 Spike S1 concentration over a wide range with a limit of detection of 1.2 pg/mL. The immunosensor has an excellent stability and achieved the detection of SARS-CoV-2 Spike S1 in river and urban wastewater, which supplies a feasible and reliable sensing platform for early virus detection and therefore to protect the population. The detection of SARS-CoV-2 Spike S1 in urban wastewater can be used as a tool to measure the circulation of the virus in the population and to detect a possible resurgence of COVID-19.
Collapse
Affiliation(s)
| | | | | | - Mónica Revenga-Parra
- Departamento de Química Analítica y Análisis Instrumental, Spain; Institute for Advanced Research in Chemical Sciences (IAdChem), Universidad Autónoma de Madrid, Ciudad Universitaria de Cantoblanco, 28049, Madrid, Spain; IMDEA-Nanociencia, Ciudad Universitaria de Cantoblanco, 28049, Madrid, Spain
| | - Félix Pariente
- Departamento de Química Analítica y Análisis Instrumental, Spain; Institute for Advanced Research in Chemical Sciences (IAdChem), Universidad Autónoma de Madrid, Ciudad Universitaria de Cantoblanco, 28049, Madrid, Spain
| | - Encarnación Lorenzo
- Departamento de Química Analítica y Análisis Instrumental, Spain; Institute for Advanced Research in Chemical Sciences (IAdChem), Universidad Autónoma de Madrid, Ciudad Universitaria de Cantoblanco, 28049, Madrid, Spain; IMDEA-Nanociencia, Ciudad Universitaria de Cantoblanco, 28049, Madrid, Spain.
| |
Collapse
|
12
|
Arafa KK, Ibrahim A, Mergawy R, El-Sherbiny IM, Febbraio F, Hassan RYA. Advances in Cancer Diagnosis: Bio-Electrochemical and Biophysical Characterizations of Cancer Cells. MICROMACHINES 2022; 13:mi13091401. [PMID: 36144024 PMCID: PMC9504238 DOI: 10.3390/mi13091401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/26/2022] [Revised: 08/21/2022] [Accepted: 08/23/2022] [Indexed: 05/09/2023]
Abstract
Cancer is a worldwide leading cause of death, and it is projected that newly diagnosed cases globally will reach 27.5 million each year by 2040. Cancers (malignant tumors), unlike benign tumors are characterized by structural and functional dedifferentiation (anaplasia), breaching of the basement membrane, spreading to adjacent tissues (invasiveness), and the capability to spread to distant sites (metastasis). In the cancer biology research field, understanding and characterizing cancer metastasis as well as features of cell death (apoptosis) is considered a technically challenging subject of study and clinically is very critical and necessary. Therefore, in addition to the cytochemical methods traditionally used, novel biophysical and bioelectrochemical techniques (e.g., cyclic voltammetry and electrochemical impedance spectroscopy), atomic force microscopy, and electron microscopic methods are increasingly being deployed to better understand these processes. Implementing those methods at the preclinical level enables the rapid screening of new anticancer drugs with understanding of their central mechanism for cancer therapy. In this review, principles and basic concepts of new techniques suggested for metastasis, and apoptosis examinations for research purposes are introduced, along with examples of each technique. From our recommendations, the privilege of combining the bio-electrochemical and biosensing techniques with the conventional cytochemical methods either for research or for biomedical diagnosis should be emphasized.
Collapse
Affiliation(s)
- Kholoud K. Arafa
- Nanoscience Program, University of Science and Technology (UST), Zewail City of Science and Technology, Giza 12578, Egypt
| | - Alaa Ibrahim
- Nanoscience Program, University of Science and Technology (UST), Zewail City of Science and Technology, Giza 12578, Egypt
| | - Reem Mergawy
- Nanoscience Program, University of Science and Technology (UST), Zewail City of Science and Technology, Giza 12578, Egypt
| | - Ibrahim M. El-Sherbiny
- Nanoscience Program, University of Science and Technology (UST), Zewail City of Science and Technology, Giza 12578, Egypt
| | - Ferdinando Febbraio
- Institute of Biochemistry and Cell Biology, National Research Council (CNR), Via P. Castellino 111, 80131 Naples, Italy
| | - Rabeay Y. A. Hassan
- Nanoscience Program, University of Science and Technology (UST), Zewail City of Science and Technology, Giza 12578, Egypt
- Correspondence: ; Tel.: +20-1129216152
| |
Collapse
|
13
|
Białobrzeska W, Ficek M, Dec B, Osella S, Trzaskowski B, Jaramillo-Botero A, Pierpaoli M, Rycewicz M, Dashkevich Y, Łęga T, Malinowska N, Cebula Z, Bigus D, Firganek D, Bięga E, Dziąbowska K, Brodowski M, Kowalski M, Panasiuk M, Gromadzka B, Żołędowska S, Nidzworski D, Pyrć K, Goddard WA, Bogdanowicz R. Performance of electrochemical immunoassays for clinical diagnostics of SARS-CoV-2 based on selective nucleocapsid N protein detection: Boron-doped diamond, gold and glassy carbon evaluation. Biosens Bioelectron 2022; 209:114222. [PMID: 35430407 PMCID: PMC8989705 DOI: 10.1016/j.bios.2022.114222] [Citation(s) in RCA: 17] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2021] [Revised: 03/17/2022] [Accepted: 03/24/2022] [Indexed: 01/09/2023]
Abstract
The 21st century has already brought us a plethora of new threats related to viruses that emerge in humans after zoonotic transmission or drastically change their geographic distribution or prevalence. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first spotted at the end of 2019 to rapidly spread in southwest Asia and later cause a global pandemic, which paralyzes the world since then. We have designed novel immunosensors targeting conserved protein sequences of the N protein of SARS-CoV-2 based on lab-produced and purified anti-SARS-CoV-2 nucleocapsid antibodies that are densely grafted onto various surfaces (diamond/gold/glassy carbon). Titration of antibodies shows very strong reactions up to 1:72 900 dilution. Next, we showed the mechanism of interactions of our immunoassay with nucleocapsid N protein revealing molecular recognition by impedimetric measurements supported by hybrid modeling results with both density functional theory and molecular dynamics methods. Biosensors allowed for a fast (in less than 10 min) detection of SARS-CoV-2 virus with a limit of detection from 0.227 ng/ml through 0.334 ng/ml to 0.362 ng/ml for glassy carbon, boron-doped diamond, and gold surfaces, respectively. For all tested surfaces, we obtained a wide linear range of concentrations from 4.4 ng/ml to 4.4 pg/ml. Furthermore, our sensor leads to a highly specific response to SARS-CoV-2 clinical samples versus other upper respiratory tract viruses such as influenza, respiratory syncytial virus, or Epstein-Barr virus. All clinical samples were tested simultaneously on biosensors and real-time polymerase chain reactions.
Collapse
|
14
|
Ahmed WS, Philip AM, Biswas KH. Decreased Interfacial Dynamics Caused by the N501Y Mutation in the SARS-CoV-2 S1 Spike:ACE2 Complex. Front Mol Biosci 2022; 9:846996. [PMID: 35936792 PMCID: PMC9355283 DOI: 10.3389/fmolb.2022.846996] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2022] [Accepted: 04/28/2022] [Indexed: 12/24/2022] Open
Abstract
Coronavirus Disease of 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has resulted in a massive health crisis across the globe, with some genetic variants gaining enhanced infectivity and competitive fitness, and thus significantly aggravating the global health concern. In this regard, the recent SARS-CoV-2 alpha, beta, and gamma variants (B.1.1.7, B.1.351, and P.1 lineages, respectively) are of great significance in that they contain several mutations that increase their transmission rates as evident from clinical reports. By the end of March 2021, these variants were accounting for about two-thirds of SARS-CoV-2 variants circulating worldwide. Specifically, the N501Y mutation in the S1 spike receptor binding domain (S1-RBD) of these variants have been reported to increase its affinity for ACE2, although the basis for this is not entirely clear yet. Here, we dissect the mechanism underlying the increased binding affinity of the N501Y mutant for ACE2 using molecular dynamics (MD) simulations of the available ACE2-S1-RBD complex structure (6M0J) and show a prolonged and stable interfacial interaction of the N501Y mutant S1-RBD with ACE2 compared to the wild type S1-RBD. Additionally, we find that the N501Y mutant S1-RBD displays altered dynamics that likely aids in its enhanced interaction with ACE2. By elucidating a mechanistic basis for the increased affinity of the N501Y mutant S1-RBD for ACE2, we believe that the results presented here will aid in developing therapeutic strategies against SARS-CoV-2 including designing of therapeutic agents targeting the ACE2-S1-RBD interaction.
Collapse
Affiliation(s)
- Wesam S. Ahmed
- Division of Biological and Biomedical Sciences, College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar
| | - Angelin M. Philip
- Division of Genomics and Translational Biomedicine, College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar
| | - Kabir H. Biswas
- Division of Biological and Biomedical Sciences, College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar
- *Correspondence: Kabir H. Biswas,
| |
Collapse
|
15
|
Fortunati S, Giannetto M, Giliberti C, Bolchi A, Ferrari D, Locatelli M, Bianchi V, Boni A, De Munari I, Careri M. Smart Immunosensors for Point-of-Care Serological Tests Aimed at Assessing Natural or Vaccine-Induced SARS-CoV-2 Immunity. SENSORS (BASEL, SWITZERLAND) 2022; 22:5463. [PMID: 35891142 PMCID: PMC9325165 DOI: 10.3390/s22145463] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 06/16/2022] [Revised: 07/15/2022] [Accepted: 07/19/2022] [Indexed: 06/15/2023]
Abstract
Innovative and highly performing smart voltammetric immunosensors for rapid and effective serological tests aimed at the determination of SARS-CoV-2 antibodies were developed and validated in human serum matrix. Two immunosensors were developed for the determination of immunoglobulins directed against either the nucleocapsid or the spike viral antigen proteins. The immunosensors were realized using disposable screen-printed electrodes modified with nanostructured materials for the immobilization of the antigens. Fast quantitative detection was achieved, with analysis duration being around 1 h. Signal readout was carried out through a smart, compact and battery-powered potentiostat, based on a Wi-Fi protocol and devised for the Internet of Things (IoT) paradigm. This device is used for the acquisition, storage and sharing of clinical data. Outstanding immunosensors' sensitivity, specificity and accuracy (100%) were assessed, according to the diagnostic guidelines for epidemiological data. The overall performance of the sensing devices, combined with the portability of the IoT-based device, enables their suitability as a high-throughput diagnostic tool. Both of the immunosensors were validated using clinical human serum specimens from SARS-CoV-2 infected patients, provided by IRCCS Ospedale San Raffaele.
Collapse
Affiliation(s)
- Simone Fortunati
- Dipartimento di Scienze Chimiche, della Vita e della Sostenibilità Ambientale, Università di Parma, Parco Area delle Scienze 17/A, 43124 Parma, Italy; (S.F.); (C.G.); (A.B.); (D.F.)
| | - Marco Giannetto
- Dipartimento di Scienze Chimiche, della Vita e della Sostenibilità Ambientale, Università di Parma, Parco Area delle Scienze 17/A, 43124 Parma, Italy; (S.F.); (C.G.); (A.B.); (D.F.)
| | - Chiara Giliberti
- Dipartimento di Scienze Chimiche, della Vita e della Sostenibilità Ambientale, Università di Parma, Parco Area delle Scienze 17/A, 43124 Parma, Italy; (S.F.); (C.G.); (A.B.); (D.F.)
| | - Angelo Bolchi
- Dipartimento di Scienze Chimiche, della Vita e della Sostenibilità Ambientale, Università di Parma, Parco Area delle Scienze 17/A, 43124 Parma, Italy; (S.F.); (C.G.); (A.B.); (D.F.)
| | - Davide Ferrari
- Dipartimento di Scienze Chimiche, della Vita e della Sostenibilità Ambientale, Università di Parma, Parco Area delle Scienze 17/A, 43124 Parma, Italy; (S.F.); (C.G.); (A.B.); (D.F.)
| | | | - Valentina Bianchi
- Dipartimento di Ingegneria e Architettura, Università di Parma, Parco Area delle Scienze 181/A, 43124 Parma, Italy; (V.B.); (A.B.); (I.D.M.)
| | - Andrea Boni
- Dipartimento di Ingegneria e Architettura, Università di Parma, Parco Area delle Scienze 181/A, 43124 Parma, Italy; (V.B.); (A.B.); (I.D.M.)
| | - Ilaria De Munari
- Dipartimento di Ingegneria e Architettura, Università di Parma, Parco Area delle Scienze 181/A, 43124 Parma, Italy; (V.B.); (A.B.); (I.D.M.)
| | - Maria Careri
- Dipartimento di Scienze Chimiche, della Vita e della Sostenibilità Ambientale, Università di Parma, Parco Area delle Scienze 17/A, 43124 Parma, Italy; (S.F.); (C.G.); (A.B.); (D.F.)
| |
Collapse
|
16
|
Shukla SK, Patra S, Das TR, Kumar D, Mishra A, Tiwari A. Progress in COVID research and developments during pandemic. VIEW 2022; 3:20210020. [PMID: 35941909 PMCID: PMC9350081 DOI: 10.1002/viw.20210020] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2021] [Revised: 04/09/2022] [Accepted: 06/14/2022] [Indexed: 11/25/2022] Open
Abstract
The pandemic respiratory disease COVID-19 has spread over the globe within a small span of time. Generally, there are two important points are being highlighted and considered towards the successful diagnosis and treatment process. The first point includes the reduction of the rate of infections and the next one is the decrease of the death rate. The major threat to public health globally progresses due to the absence of effective medication and widely accepted immunization for the COVID-19. Whereas, understanding of host susceptibility, clinical features, adaptation of COVID-19 to new environments, asymptomatic infection is difficult and challenging. Therefore, a rapid and an exact determination of pathogenic viruses play an important role in deciding treatments and preventing pandemic to save the people's lives. It is urgent to fix a standardized diagnostic approach for detecting the COVID-19. Here, this systematic review describes all the current approaches using for screening and diagnosing the COVID-19 infectious patient. The renaissance in pathogen due to host adaptability and new region, facing creates several obstacles in diagnosis, drug, and vaccine development process. The study shows that adaptation of accurate and affordable diagnostic tools based on candidate biomarkers using sensor and digital medicine technology can deliver effective diagnosis services at the mass level. Better prospects of public health management rely on diagnosis with high specificity and cost-effective manner along with multidisciplinary research, specific policy, and technology adaptation. The proposed healthcare model with defined road map represents effective prognosis system.
Collapse
Affiliation(s)
- Sudheesh K. Shukla
- Institute of Advanced MaterialsIAAMGammalkilsvägen 18Ulrika59053Sweden
- VBRI Innovation Centre7/16 Kalkaji ExtnNew Delhi110019India
| | - Santanu Patra
- Institute of Advanced MaterialsIAAMGammalkilsvägen 18Ulrika59053Sweden
- VBRI Innovation Centre7/16 Kalkaji ExtnNew Delhi110019India
| | - Trupti R. Das
- CIPET, Institute of Petrochemicals Technology (IPT)‐BhubaneswarPatiaBhubaneswarIndia
| | - Dharmesh Kumar
- VBRI Innovation Centre7/16 Kalkaji ExtnNew Delhi110019India
| | - Anshuman Mishra
- Institute of Advanced MaterialsIAAMGammalkilsvägen 18Ulrika59053Sweden
| | - Ashutosh Tiwari
- Institute of Advanced MaterialsIAAMGammalkilsvägen 18Ulrika59053Sweden
| |
Collapse
|
17
|
Li C, Guo Y, Fang Z, Zhang H, Zhang Y, Chen K. Analysis of the Protective Efficacy of Approved COVID-19 Vaccines Against Various Mutants. Front Immunol 2022; 13:804945. [PMID: 35572594 PMCID: PMC9095899 DOI: 10.3389/fimmu.2022.804945] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2021] [Accepted: 04/04/2022] [Indexed: 11/30/2022] Open
Abstract
The outbreak of COVID-19 (caused by SARS-CoV-2) has posed a significant threat to global public health security because of its high pathogenicity and infectivity. To date, the pathogenic mechanism of this novel coronavirus (SARS-CoV-2) is still unclear, and there is no effective treatment. As one of the most effective strategies to prevent viral infection, vaccines have become a research hotspot. Based on the current understanding of SARS-CoV-2, the research and development of its vaccines cover almost all forms of current vaccine research, including inactivated vaccines, recombinant protein vaccines, viral vector vaccines, and nucleic acid vaccines. Moreover, with the spread of the new mutant virus, it is necessary to evaluate the protection rate of previous administered vaccines. This article reviews the candidate targets, vaccine types, research and development status, progress of SARS-CoV-2 vaccines, and the effectiveness of neutralizing antibodies against SARS-CoV-2 mutants (B.1.1.7, B.1.351, P.1, B.1.617.2, and B.1.1.529) induced by these vaccines, to provide a reference for follow-up research and prevention.
Collapse
Affiliation(s)
- Chaonan Li
- Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China
| | - Yikai Guo
- Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China
| | - Zhongbiao Fang
- Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China
| | - Haiyan Zhang
- Zhejiang Shuren College, Zhejiang Chinese Medical University, Hangzhou, China
| | - Yanjun Zhang
- Department of Virus Inspection, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China
| | - Keda Chen
- Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China
| |
Collapse
|
18
|
Molecularly Imprinted Polymer-Based Sensors for SARS-CoV-2: Where Are We Now? Biomimetics (Basel) 2022; 7:biomimetics7020058. [PMID: 35645185 PMCID: PMC9149885 DOI: 10.3390/biomimetics7020058] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2022] [Revised: 05/03/2022] [Accepted: 05/04/2022] [Indexed: 01/27/2023] Open
Abstract
Since the first reported case of COVID-19 in 2019 in China and the official declaration from the World Health Organization in March 2021 as a pandemic, fast and accurate diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has played a major role worldwide. For this reason, various methods have been developed, comprising reverse transcriptase-polymerase chain reaction (RT-PCR), immunoassays, clustered regularly interspaced short palindromic repeats (CRISPR), reverse transcription loop-mediated isothermal amplification (RT-LAMP), and bio(mimetic)sensors. Among the developed methods, RT-PCR is so far the gold standard. Herein, we give an overview of the MIP-based sensors utilized since the beginning of the pandemic.
Collapse
|
19
|
Gold Nanoparticle-Mediated Lateral Flow Assays for Detection of Host Antibodies and COVID-19 Proteins. NANOMATERIALS 2022; 12:nano12091456. [PMID: 35564165 PMCID: PMC9102158 DOI: 10.3390/nano12091456] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/20/2022] [Revised: 04/17/2022] [Accepted: 04/19/2022] [Indexed: 01/15/2023]
Abstract
Coronaviruses, that are now well-known to the public, include a family of viruses that can cause severe acute respiratory syndrome (SARS) and other respiratory diseases, such as Middle East respiratory syndrome (MERS). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the seventh member of this coronavirus family, was detected in 2019 and can cause a number of respiratory symptoms, from dry cough and fever to fatal viral pneumonia. Various diagnostic assays ranging from real-time polymerase chain reaction (RT-PCR) to point-of-care medical diagnostic systems have been developed for detection of viral components or antibodies targeting the virus. Point-of-care assays allow rapid diagnostic assessment of infectious patients. Such assays are ideally simple, low-cost, portable tests with the possibility for on-site field detection that do not require skilled staff, sophisticated equipment, or sample pretreatment, as compared to RT-PCR. Since early 2021 when new SARS-CoV-2 variants of concern increased, rapid tests became more crucial in the disease management cycle. Among rapid tests, gold nanoparticle (GNP)-based lateral flow assays (LFAs) have high capacity for performing at the bedside, paving the way to easy access to diagnosis results. In this review, GNP-based LFAs used for either COVID-19 proteins or human response antibodies are summarized and recommendations for their improvement have been suggested.
Collapse
|
20
|
A Low-Current and Multi-Channel Chemiresistor Array Sensor Device. SENSORS 2022; 22:s22072781. [PMID: 35408393 PMCID: PMC9003399 DOI: 10.3390/s22072781] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/04/2022] [Revised: 03/28/2022] [Accepted: 04/01/2022] [Indexed: 02/04/2023]
Abstract
This paper describes the design of a low-current, multichannel, handheld electronic device integrated with nanostructured chemiresistor sensor arrays. A key design feature of the electronic circuit board is its low excitation current for achieving optimal performance with the arrays. The electronics can rapidly acquire the resistances for different sensors, not only spanning several orders of magnitude, but also as high as several hundreds of megaohms. The device tested is designed using a chemiresistor array with nanostructured sensing films prepared by molecularly-mediated assemblies of gold nanoparticles for detection. The low-current, wide-range, and auto-locking capabilities, along with the effective coupling with the nanostructured chemiresistor arrays, meet the desired performances of a low excitation current and low power consumption, and also address the potential instability of the sensors in a complex sensing environment. The results are promising for potential applications of the device as a portable sensor for the point-of-need monitoring of air quality and as a biosensor for point-of-care human breath screening for disease biomarkers.
Collapse
|
21
|
Malla P, Liao HP, Liu CH, Wu WC, Sreearunothai P. Voltammetric biosensor for coronavirus spike protein using magnetic bead and screen-printed electrode for point-of-care diagnostics. Mikrochim Acta 2022; 189:168. [PMID: 35362759 PMCID: PMC8973645 DOI: 10.1007/s00604-022-05288-4] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2021] [Accepted: 03/19/2022] [Indexed: 12/29/2022]
Abstract
The rapid spread of the novel human coronavirus 2019 (COVID-19) and its morbidity have created an urgent need for rapid and sensitive diagnostics. The real-time polymerase chain reaction is the gold standard for detecting the coronavirus in various types of biological specimens. However, this technique is time consuming, labor intensive, and expensive. Screen-printed electrodes (SPEs) can be used as point-of-care devices because of their low cost, sensitivity, selectivity, and ability to be miniaturized. The ability to detect the spike protein of COVID-19 in serum, urine, and saliva was developed using SPE aided by magnetic beads (MBs) and a portable potentiostat. The antibody-peroxidase-loaded MBs were the captured and catalytic units for the electrochemical assays. The MBs enable simple washing and homogenous deposition on the working electrode using a magnet. The assembly of the immunological MBs and the electrochemical system increases the measuring sensitivity and speed. The physical and electrochemical properties of the layer-by-layer modified MBs were systematically characterized. The performance of these immunosensors was evaluated using spike protein in the range 3.12–200 ng mL−1. We achieved a limit of detection of 0.20, 0.31, and 0.54 ng mL−1 in human saliva, urine, and serum, respectively. A facile electrochemical method to detect COVID-19 spike protein was developed for quick point-of-care testing.
Collapse
Affiliation(s)
- Pravanjan Malla
- Department of Chemical and Materials Engineering, Chang Gung University, 259, Wen-Hwa First Road, Taoyuan, Taiwan
| | - Hao-Ping Liao
- Department of Chemical and Materials Engineering, Chang Gung University, 259, Wen-Hwa First Road, Taoyuan, Taiwan
| | - Chi-Hsien Liu
- Department of Chemical and Materials Engineering, Chang Gung University, 259, Wen-Hwa First Road, Taoyuan, Taiwan. .,Research Center for Chinese Herbal Medicine and Research Center for Food and Cosmetic Safety, College of Human Ecology, Chang Gung University of Science and Technology, 261, Wen-Hwa First Road, Taoyuan, Taiwan. .,Department of Chemical Engineering, Ming Chi University of Technology, 84, Gung-Juan Road, New Taipei City, Taiwan. .,Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, 5, Fu-Hsing Street, Taoyuan, Taiwan.
| | - Wei-Chi Wu
- Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, 5, Fu-Hsing Street, Taoyuan, Taiwan.,College of Medicine, Chang Gung University, 259, Wen-Hwa First Road, Taoyuan, Taiwan
| | - Paiboon Sreearunothai
- Sirindhorn International Institute of Technology, Thammasat University, Pathum Thani, Thailand
| |
Collapse
|
22
|
Tang Y, Wang Y, Li Y, Zhao H, Zhang S, Zhang Y, Li J, Chen Y, Wu X, Qin C, Jiang T, Kang X. An Integrated Rapid Nucleic Acid Detection Assay Based on Recombinant Polymerase Amplification for SARS-CoV-2. Virol Sin 2022; 37:138-141. [PMID: 35234627 PMCID: PMC8755414 DOI: 10.1016/j.virs.2022.01.006] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2021] [Accepted: 09/30/2021] [Indexed: 11/24/2022] Open
Abstract
I-RPA was developed by combining sample treatment and RPA detection in a single sealed cartridge. No cross reaction was found in respiratory tract-associated viruses. The low limit of detection was 35 copies/reaction. This I-RPA assay is suitable for detection and monitoring of SARS-CoV-2 in the field.
Collapse
|
23
|
Development of corona sensor. SENSING TOOLS AND TECHNIQUES FOR COVID-19 2022. [PMCID: PMC9335065 DOI: 10.1016/b978-0-323-90280-9.00012-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The outbreak of corona virus (COVID-19) has imposed serious concern all over the world as many part of the globe have been severely affected by this. It has become essential to develop efficient methods for the treatment and detection of this virus. Among the new approaches, the nanosensor has played a vital role in tracing and detecting the virus. Sensors are tools to assist detect events or changes in the environment while also sending data to other electronics, most commonly a computer processor. This chapter contains the approach followed and development in several biosensors, wearable sensor, and colorimetric sensors toward the identification of corona virus.
Collapse
|
24
|
Bakhtazad A, Garmabi B, Joghataei MT. Neurological manifestations of coronavirus infections, before and after COVID-19: a review of animal studies. J Neurovirol 2021; 27:864-884. [PMID: 34727365 PMCID: PMC8561685 DOI: 10.1007/s13365-021-01014-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2020] [Revised: 07/15/2021] [Accepted: 08/20/2021] [Indexed: 12/12/2022]
Abstract
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This virus, which was first identified in December 2019 in China, has resulted in a yet ongoing viral pandemic. Coronaviridae could potentially cause several disorders in a wide range of hosts such as birds and mammals. Although infections caused by this family of viruses are predominantly limited to the respiratory tract, Betacoronaviruses are potentially able to invade the central nervous system (CNS) as well as many other organs, thereby inducing neurological damage ranging from mild to lethal in both animals and humans. Over the past two decades, three novel CoVs, SARS-CoV-1, MERS-CoV, and SARS-CoV-2, emerging from animal reservoirs have exhibited neurotropic properties causing severe and even fatal neurological diseases. The pathobiology of these neuroinvasive viruses has yet to be fully known. Both clinical features of the previous CoV epidemics (SARS-CoV-1 and MERS-CoV) and lessons from animal models used in studying neurotropic CoVs, especially SARS and MERS, constitute beneficial tools in comprehending the exact mechanisms of virus implantation and in illustrating pathogenesis and virus dissemination pathways in the CNS. Here, we review the animal research which assessed CNS infections with previous more studied neurotropic CoVs to demonstrate how experimental studies with appliable animal models can provide scientists with a roadmap in the CNS impacts of SARS-CoV-2. Indeed, animal studies can finally help us discover the underlying mechanisms of damage to the nervous system in COVID-19 patients and find novel therapeutic agents in order to reduce mortality and morbidity associated with neurological complications of SARS-CoV-2 infection.
Collapse
Affiliation(s)
- Atefeh Bakhtazad
- Cellular and Molecular Research Center (CMRC), Iran University of Medical Sciences, 1449614535 Tehran, Iran
| | - Behzad Garmabi
- School of Medicine, Shahroud University of Medical Sciences, Haft-Tir Sq, University Blv, 3614773947 Shahroud, Iran
| | - Mohammad Taghi Joghataei
- Cellular and Molecular Research Center (CMRC), Iran University of Medical Sciences, 1449614535 Tehran, Iran
| |
Collapse
|
25
|
Lima NM, Fernandes BL, Alves GF, de Souza JC, Siqueira MM, Patrícia do Nascimento M, Moreira OB, Sussulini A, de Oliveira MA. Mass spectrometry applied to diagnosis, prognosis, and therapeutic targets identification for the novel coronavirus SARS-CoV-2: A review. Anal Chim Acta 2021; 1195:339385. [PMID: 35090661 PMCID: PMC8687343 DOI: 10.1016/j.aca.2021.339385] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2021] [Revised: 12/16/2021] [Accepted: 12/17/2021] [Indexed: 12/27/2022]
Abstract
Mass spectrometry (MS) has found numerous applications in medicine and has been widely used in the detection and characterization of biomolecules associated with viral infections such as COVID-19. COVID-19 is a multisystem disease and, therefore, the need arises to carry out a careful and conclusive assessment of the pathophysiological parameters involved in the infection, to develop an effective therapeutic approach, assess the prognosis of the disease, and especially the early diagnosis of the infected population. Thus, the urgent need for highly accurate methods of diagnosis and prognosis of this infection presents new challenges for the development of laboratory medicine, whose methods require sensitivity, speed, and accuracy of the techniques for analyzing the biological markers involved in the infection. In this context, MS stands out as a robust analytical tool, with high sensitivity and selectivity, accuracy, low turnaround time, and versatility for the analysis of biological samples. However, it has not yet been adopted as a frontline clinical laboratory technique. Therefore, this review explores the potential and trends of current MS methods and their contribution to the development of new strategies to COVID-19 diagnosis and prognosis and how this tool can assist in the discovery of new therapeutic targets, in addition, to comment what could be the future of MS in medicine.
Collapse
|
26
|
Hussein HA, Kandeil A, Gomaa M, Mohamed El Nashar R, El-Sherbiny IM, Hassan RYA. SARS-CoV-2-Impedimetric Biosensor: Virus-Imprinted Chips for Early and Rapid Diagnosis. ACS Sens 2021; 6:4098-4107. [PMID: 34757734 PMCID: PMC8592124 DOI: 10.1021/acssensors.1c01614] [Citation(s) in RCA: 36] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2021] [Accepted: 11/01/2021] [Indexed: 12/19/2022]
Abstract
Due to the current global SARS-CoV-2 pandemic, rapid and accurate diagnostic tools are needed to prevent the spread of COVID-19 across the globe. An electrochemical sensing platform was constructed using CNTs/WO3-screen printed electrodes for imprinting the complete virus particles (SARS-CoV-2 particles) within the polymeric matrix to create viral complementary binding sites. The sensor provided high selectivity toward the target virus over other tested human corona and influenza respiratory interference viruses. The sensitivity performance of the sensor chips was evaluated using different viral concentrations, while the limits of detection and quantification were 57 and 175 pg/mL, respectively. Reaching this satisfied low detection limit (almost 27-fold more sensitive than the RT-PCR), the sensor was applied in clinical specimens obtained from SARS-CoV-2 suspected cases. Thus, dealing directly with clinical samples on the chip could be provided as a portable device for instantaneous and simple point of care in hospitals, airports, and hotspots.
Collapse
Affiliation(s)
- Heba A. Hussein
- Virology Department, Animal Health
Research Institute (AHRI), Agricultural Research Center (ARC), Giza 12619,
Egypt
| | - Ahmed Kandeil
- Center of Scientific Excellence for Influenza Viruses,
Environmental Research Division, National Research Centre, Giza
12622, Egypt
| | - Mokhtar Gomaa
- Center of Scientific Excellence for Influenza Viruses,
Environmental Research Division, National Research Centre, Giza
12622, Egypt
| | | | - Ibrahim M. El-Sherbiny
- Nanoscience Program, University of
Science and Technology (UST), Zewail City of Science and Technology, Giza
12578, Egypt
| | - Rabeay Y. A. Hassan
- Nanoscience Program, University of
Science and Technology (UST), Zewail City of Science and Technology, Giza
12578, Egypt
- Applied Organic Chemistry Department,
National Research Centre (NRC), Dokki, 12622 Giza,
Egypt
| |
Collapse
|
27
|
Shin HS, Park H, Kwon JS, Namgoong H, Kim SJ, Kim JM, Peck KR, Lee K, Lee JK, Lee J, Han HC, Hong S, Park BJ, Lim TH, Hwang ES, Woo JH. National Academy of Medicine of Korea (NAMOK) Key Statements on COVID-19. J Korean Med Sci 2021; 36:e287. [PMID: 34697930 PMCID: PMC8546308 DOI: 10.3346/jkms.2021.36.e287] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/05/2021] [Accepted: 10/06/2021] [Indexed: 12/26/2022] Open
Affiliation(s)
- Hyoung-Shik Shin
- Department of Infectious Diseases, Daejeon Eulji Medical Center, Eulji University, Daejeon, Korea
| | - Hyesook Park
- Department of Preventive Medicine, Graduate Program in System Health Science and Engineering, Ehwa University College of Medicine, Seoul, Korea
| | - Jun Soo Kwon
- Department of Psychiatry, Seoul National University College of Medicine, Seoul, Korea
| | | | - Seong-Jun Kim
- Korea Research Institute of Chemical Technology, Daejeon, Korea
| | - June Myung Kim
- Department of Infectious Diseases, Yonsei University College of Medicine, Seoul, Korea
| | - Kyong Ran Peck
- Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - Kyungwon Lee
- Seoul Clinical Laboratories Academy, Yongin, Korea
| | - Jong-Koo Lee
- Department of Family Medicine, Seoul National University College of Medicine, Seoul, Korea
| | | | - Hee Chul Han
- Department of Physiology, Korea University College of Medicine, Seoul, Korea
| | - SungJin Hong
- Department of Anesthesiology, Catholic University of Korea College of Medicine, Seoul, Korea
| | - Byung-Joo Park
- Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea
| | - Tae Hwan Lim
- Department of Radiology, University of Ulsan College of Medicine, Ulsan, Korea
| | - Eung Soo Hwang
- Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, Korea.
| | - Jun Hee Woo
- Department of Infectious Diseases, Uijeongbu Eulji Medical Center, Eulji University, Uijeongbu, Korea.
| | | |
Collapse
|
28
|
Peng YC, Cheng CH, Yatsuda H, Liu SH, Liu SJ, Kogai T, Kuo CY, Wang RYL. A Novel Rapid Test to Detect Anti-SARS-CoV-2 N Protein IgG Based on Shear Horizontal Surface Acoustic Wave (SH-SAW). Diagnostics (Basel) 2021; 11:diagnostics11101838. [PMID: 34679536 PMCID: PMC8534600 DOI: 10.3390/diagnostics11101838] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2021] [Revised: 09/28/2021] [Accepted: 10/01/2021] [Indexed: 01/23/2023] Open
Abstract
Since the Coronavirus disease 2019 (COVID-19) pandemic outbreak, many methods have been used to detect antigens or antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), including viral culture, nucleic acid test, and immunoassay. The shear-horizontal surface acoustic wave (SH-SAW) biosensor is a novel pathogen detection platform with the advantages of high sensitivity and short detection time. The objective of this study is to develop a SH-SAW biosensor to detect the anti-SARS-CoV-2 nucleocapsid antibody. The rabbit sera collected from rabbits on different days after SARS-CoV-2 N protein injection were evaluated by SH-SAW biosensor and enzyme-linked immunosorbent assay (ELISA). The results showed that the SH-SAW biosensor achieved a high correlation coefficient (R = 0.9997) with different concentrations (34.375–1100 ng/mL) of the “spike-in” anti-N protein antibodies. Compared to ELISA, the SH-SAW biosensor has better sensitivity and can detect anti-N protein IgG signals earlier than ELISA on day 6 (p < 0.05). Overall, in this study, we demonstrated that the SH-SAW biosensor is a promising platform for rapid in vitro diagnostic (IVD) testing, especially for antigen or antibody testing.
Collapse
Affiliation(s)
- Yu-Chi Peng
- Biotechnology Industry Master and PhD Program, Chang Gung University, Taoyuan 33302, Taiwan;
| | - Chia-Hsuan Cheng
- Tst Biomedical Electronics Co., Ltd., Taoyuan 324, Taiwan; (C.-H.C.); (H.Y.); (S.-H.L.); (T.K.)
| | - Hiromi Yatsuda
- Tst Biomedical Electronics Co., Ltd., Taoyuan 324, Taiwan; (C.-H.C.); (H.Y.); (S.-H.L.); (T.K.)
| | - Szu-Heng Liu
- Tst Biomedical Electronics Co., Ltd., Taoyuan 324, Taiwan; (C.-H.C.); (H.Y.); (S.-H.L.); (T.K.)
| | - Shih-Jen Liu
- National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli 35053, Taiwan;
| | - Takashi Kogai
- Tst Biomedical Electronics Co., Ltd., Taoyuan 324, Taiwan; (C.-H.C.); (H.Y.); (S.-H.L.); (T.K.)
- Japan Radio Co., Ltd., Saitama 356-8510, Japan
| | - Chen-Yen Kuo
- Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Memorial and Children’s Hospital, Linkou 33305, Taiwan;
| | - Robert Y. L. Wang
- Biotechnology Industry Master and PhD Program, Chang Gung University, Taoyuan 33302, Taiwan;
- Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Memorial and Children’s Hospital, Linkou 33305, Taiwan;
- Department of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan
- Correspondence: ; Tel.: +886-3-2118800 (ext. 3691)
| |
Collapse
|
29
|
Electrochemical Impedance Spectroscopy (EIS): Principles, Construction, and Biosensing Applications. SENSORS 2021; 21:s21196578. [PMID: 34640898 PMCID: PMC8512860 DOI: 10.3390/s21196578] [Citation(s) in RCA: 175] [Impact Index Per Article: 58.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/30/2021] [Revised: 09/17/2021] [Accepted: 09/26/2021] [Indexed: 01/10/2023]
Abstract
Electrochemical impedance spectroscopy (EIS) is a powerful technique used for the analysis of interfacial properties related to bio-recognition events occurring at the electrode surface, such as antibody–antigen recognition, substrate–enzyme interaction, or whole cell capturing. Thus, EIS could be exploited in several important biomedical diagnosis and environmental applications. However, the EIS is one of the most complex electrochemical methods, therefore, this review introduced the basic concepts and the theoretical background of the impedimetric technique along with the state of the art of the impedimetric biosensors and the impact of nanomaterials on the EIS performance. The use of nanomaterials such as nanoparticles, nanotubes, nanowires, and nanocomposites provided catalytic activity, enhanced sensing elements immobilization, promoted faster electron transfer, and increased reliability and accuracy of the reported EIS sensors. Thus, the EIS was used for the effective quantitative and qualitative detections of pathogens, DNA, cancer-associated biomarkers, etc. Through this review article, intensive literature review is provided to highlight the impact of nanomaterials on enhancing the analytical features of impedimetric biosensors.
Collapse
|
30
|
Xue Q, Kan X, Pan Z, Li Z, Pan W, Zhou F, Duan X. An intelligent face mask integrated with high density conductive nanowire array for directly exhaled coronavirus aerosols screening. Biosens Bioelectron 2021; 186:113286. [PMID: 33990035 PMCID: PMC8091738 DOI: 10.1016/j.bios.2021.113286] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2021] [Revised: 04/19/2021] [Accepted: 04/23/2021] [Indexed: 01/10/2023]
Abstract
The current ongoing outbreak of Coronavirus Disease 2019 (COVID-19) has globally affected the lives of more than one hundred million people. RT-PCR based molecular test is recommended as the gold standard method for diagnosing current infections. However, transportation and processing of the clinical sample for detecting virus require an expert operator and long processing time. Testing device enables on-site virus detection could reduce the sample-to-answer time, which plays a central role in containing the pandemic. In this work, we proposed an intelligent face mask, where a flexible immunosensor based on high density conductive nanowire array, a miniaturized impedance circuit, and wireless communication units were embedded. The sub-100 nm size and the gap between the neighbored nanowires facilitate the locking of nanoscale virus particles by the nanowire arrays and greatly improve the detection efficiency. Such a point-of-care (POC) system was demonstrated for coronavirus 'spike' protein and whole virus aerosol detection in simulated human breath. Detection of viral concentration as low as 7 pfu/mL from the atomized sample of coronavirus aerosol mimic was achieved in only 5 min. The POC systems can be readily applied for preliminary screening of coronavirus infections on-site and may help to understand the COVID-19 progression while a patient is under prescribed therapy.
Collapse
Affiliation(s)
- Qiannan Xue
- State Key Laboratory of Precision Measuring Technology & Instruments, School of Precision Instruments and Optoelec-tronics Engineering, Tianjin University, Tianjin, 300072, China
| | - Xinyuan Kan
- State Key Laboratory of Precision Measuring Technology & Instruments, School of Precision Instruments and Optoelec-tronics Engineering, Tianjin University, Tianjin, 300072, China
| | - Zhihao Pan
- State Key Laboratory of Precision Measuring Technology & Instruments, School of Precision Instruments and Optoelec-tronics Engineering, Tianjin University, Tianjin, 300072, China
| | - Zheyu Li
- State Key Laboratory of Precision Measuring Technology & Instruments, School of Precision Instruments and Optoelec-tronics Engineering, Tianjin University, Tianjin, 300072, China
| | - Wenwei Pan
- State Key Laboratory of Precision Measuring Technology & Instruments, School of Precision Instruments and Optoelec-tronics Engineering, Tianjin University, Tianjin, 300072, China
| | - Feng Zhou
- State Key Laboratory of Precision Measuring Technology & Instruments, School of Precision Instruments and Optoelec-tronics Engineering, Tianjin University, Tianjin, 300072, China
| | - Xuexin Duan
- State Key Laboratory of Precision Measuring Technology & Instruments, School of Precision Instruments and Optoelec-tronics Engineering, Tianjin University, Tianjin, 300072, China.
| |
Collapse
|
31
|
Ogunrinola OO, Kanmodi RI, Ogunrinola OA. Medicinal plants as immune booster in the palliative management of viral diseases: A perspective on coronavirus. FOOD FRONTIERS 2021. [DOI: 10.1002/fft2.107] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Affiliation(s)
- Olabisi O. Ogunrinola
- Department of Biochemistry, Faculty of Science Lagos State University Ojo Lagos Nigeria
| | - Rahmon I. Kanmodi
- Department of Biochemistry, Faculty of Science Lagos State University Ojo Lagos Nigeria
| | | |
Collapse
|
32
|
Martín J, Tena N, Asuero AG. Current state of diagnostic, screening and surveillance testing methods for COVID-19 from an analytical chemistry point of view. Microchem J 2021; 167:106305. [PMID: 33897053 PMCID: PMC8054532 DOI: 10.1016/j.microc.2021.106305] [Citation(s) in RCA: 27] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2021] [Revised: 04/12/2021] [Accepted: 04/14/2021] [Indexed: 12/18/2022]
Abstract
Since December 2019, we have been in the battlefield with a new threat to the humanity known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this review, we describe the four main methods used for diagnosis, screening and/or surveillance of SARS-CoV-2: Real-time reverse transcription polymerase chain reaction (RT-PCR); chest computed tomography (CT); and different complementary alternatives developed in order to obtain rapid results, antigen and antibody detection. All of them compare the highlighting advantages and disadvantages from an analytical point of view. The gold standard method in terms of sensitivity and specificity is the RT-PCR. The different modifications propose to make it more rapid and applicable at point of care (POC) are also presented and discussed. CT images are limited to central hospitals. However, being combined with RT-PCR is the most robust and accurate way to confirm COVID-19 infection. Antibody tests, although unable to provide reliable results on the status of the infection, are suitable for carrying out maximum screening of the population in order to know the immune capacity. More recently, antigen tests, less sensitive than RT-PCR, have been authorized to determine in a quicker way whether the patient is infected at the time of analysis and without the need of specific instruments.
Collapse
Key Words
- 2019-nCoV, 2019 novel coronavirus
- ACE2, Angiotensin-Converting Enzyme 2
- AI, Artificial Intelligence
- ALP, Alkaline Phosphatase
- ASOs, Antisense Oligonucleotides
- Antigen and antibody tests
- AuNIs, Gold Nanoislands
- AuNPs, Gold Nanoparticles
- BSL, Biosecurity Level
- CAP, College of American Pathologists
- CCD, Charge-Coupled Device
- CG, Colloidal Gold
- CGIA, Colloidal Gold Immunochromatographic Assay
- CLIA, Chemiluminescence Enzyme Immunoassay
- CLIA, Clinical Laboratory Improvement Amendments
- COVID-19
- COVID-19, Coronavirus disease-19
- CRISPR, Clustered Regularly Interspaced Short Palindromic Repeats
- CT, Chest Computed Tomography
- Cas, CRISPR Associate Protein
- China CDC, Chinese Center for Disease Control and Prevention
- Ct, Cycle Threshold
- DETECTR, SARS-CoV-2 DNA Endonuclease-Targeted CRISPR Trans Reporter
- DNA, Dexosyrosyribonucleic Acid
- E, Envelope protein
- ELISA, Enzyme Linked Immunosorbent Assay
- EMA, European Medicines Agency
- EUA, Emergence Use Authorization
- FDA, Food and Drug Administration
- FET, Field-Effect Transistor
- GISAID, Global Initiative on Sharing All Influenza Data
- GeneBank, Genetic sequence data base of the National Institute of Health
- ICTV, International Committee on Taxonomy of Viruses
- IgA, Immunoglobulins A
- IgG, Immunoglobulins G
- IgM, Immunoglobulins M
- IoMT, Internet of Medical Things
- IoT, Internet of Things
- LFIA, Lateral Flow Immunochromatographic Assays
- LOC, Lab-on-a-Chip
- LOD, Limit of detection
- LSPR, Localized Surface Plasmon Resonance
- M, Membrane protein
- MERS-CoV, Middle East Respiratory Syndrome Coronavirus
- MNP, Magnetic Nanoparticle
- MS, Mass spectrometry
- N, Nucleocapsid protein
- NER, Naked Eye Readout
- NGM, Next Generation Molecular
- NGS, Next Generation Sequencing
- NIH, National Institute of Health
- NSPs, Nonstructural Proteins
- Net, Neural Network
- ORF, Open Reading Frame
- OSN, One Step Single-tube Nested
- PDMS, Polydimethylsiloxane
- POC, Point of Care
- PPT, Plasmonic Photothermal
- QD, Quantum Dot
- R0, Basic reproductive number
- RBD, Receptor-binding domain
- RNA, Ribonucleic Acid
- RNaseH, Ribonuclease H
- RT, Reverse Transcriptase
- RT-LAMP, Reverse Transcription Loop-Mediated Isothermal Amplification
- RT-PCR, Real-Time Reverse Transcription Polymerase Chain Reaction
- RT-PCR, chest computerized tomography
- RdRp, RNA-Dependent RNA Polymerase
- S, Spike protein
- SARS-CoV-2
- SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2
- SERS, Surface Enhanced Raman Spectroscopy
- SHERLOCK, Specific High Sensitivity Enzymatic Reporter UnLOCKing
- STOPCovid, SHERLOCK Testing on One Pot
- SVM, Support Vector Machine
- SiO2@Ag, Complete silver nanoparticle shell coated on silica core
- US CDC, US Centers for Disease Control and Prevention
- VOC, Variant of Concern
- VTM, Viral Transport Medium
- WGS, Whole Genome Sequencing
- WHO, World Health Organization
- aM, Attomolar
- dNTPs, Nucleotides
- dPCR, Digital PCR
- ddPCR, Droplet digital PCR
- fM, Femtomolar
- m-RNA, Messenger Ribonucleic Acid
- nM, Nanomolar
- pM, Picomolar
- pfu, Plaque-forming unit
- rN, Recombinant nucleocapsid protein antigen
- rS, Recombinant Spike protein antigen
- ssRNA, Single-Stranded Positive-Sense RNA
Collapse
Affiliation(s)
- Julia Martín
- Departamento de Química Analítica, Escuela Politécnica Superior, Universidad de Sevilla, C/ Virgen de África 7, Sevilla E-41011, Spain
| | - Noelia Tena
- Departamento de Química Analítica, Facultad de Farmacia, Universidad de Sevilla, Prof. García González, 2, Sevilla 41012, Spain
| | - Agustin G Asuero
- Departamento de Química Analítica, Facultad de Farmacia, Universidad de Sevilla, Prof. García González, 2, Sevilla 41012, Spain
| |
Collapse
|
33
|
Hussein HA, El Nashar RM, El-Sherbiny IM, Hassan RYA. High selectivity detection of FMDV- SAT-2 using a newly-developed electrochemical nanosensors. Biosens Bioelectron 2021; 191:113435. [PMID: 34175651 DOI: 10.1016/j.bios.2021.113435] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2021] [Revised: 06/07/2021] [Accepted: 06/10/2021] [Indexed: 01/10/2023]
Abstract
Foot-and-mouth disease virus serotype South-Africa territories-2 (FMDV-SAT-2) is the most fastidious known type in Aphthovirus which is subsequently reflected in the diagnosis regime. Rapid and early diagnostic actions are usually taken in response to the FMDV outbreak to prevent the dramatic spread of the disease. Virus imprinted sensor (VIP sensor) is gathering huge attention for the selective detection of pathogens. Thus, the whole virus particles of SAT-2 together with an electropolymerized film of poly(o-phenylenediamine) (PoPD) on gold-copper modified screen-printed electrode were applied to fabricate SAT-2-virus imprinted polymer (SAT-2-VIP). The SAT-2-VIPs were fully characterized using cyclic voltammetry (CV), linear sweep voltammetry (LSV), Atomic force microscopy (AFM), Scanning electron microscope (SEM), and Fourier transform Infra-Red (FTIR) spectroscopy. Excellent selective binding affinity towards the targeted virus particle was achieved with limits of detection and quantification of 0.1 ng/mL and 0.4 ng/mL, respectively. In terms of viral interference, the sensor did not show cross-reactivity towards other animal viruses including FMDV serotype A, O, or even SAT-2 subtype Libya and the un-related virus Lumpy skin disease virus (LSDV). This high selectivity provides a sensible platform with 70 folds more sensitivity than the reference RT-PCR as revealed from the application of SAT-2-VIP sensor for rapid analysis of clinical samples with no need for treatment or equipped labs. Thus, as diagnostic and surveillance technologies, on-site point of care diagnostics for SAT-2 virus are supported.
Collapse
Affiliation(s)
- Heba A Hussein
- Center for Materials Science, Zewail City of Science and Technology, 6th October City, 12578, Giza, Egypt; Virology Department, Animal Health Research Institute (AHRI), Agricultural Research Center (ARC), Giza, 12619, Egypt
| | | | - Ibrahim M El-Sherbiny
- Center for Materials Science, Zewail City of Science and Technology, 6th October City, 12578, Giza, Egypt.
| | - Rabeay Y A Hassan
- Center for Materials Science, Zewail City of Science and Technology, 6th October City, 12578, Giza, Egypt; Applied Organic Chemistry Department, National Research Centre (NRC), Dokki, 12622, Giza, Egypt.
| |
Collapse
|
34
|
Chen Y, Hu M, Hua C, Zhai G, Zhang J, Li Q, Yang SX. Face Mask Assistant: Detection of Face Mask Service Stage Based on Mobile Phone. IEEE SENSORS JOURNAL 2021; 21:11084-11093. [PMID: 36820762 PMCID: PMC8768979 DOI: 10.1109/jsen.2021.3061178] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/27/2021] [Revised: 02/18/2021] [Accepted: 02/19/2021] [Indexed: 05/10/2023]
Abstract
Coronavirus Disease 2019 (COVID-19) has spread all over the world since it broke out massively in December 2019, which has caused a large loss to the whole world. Both the confirmed cases and death cases have reached a relatively frightening number. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of COVID-19, can be transmitted by small respiratory droplets. To curb its spread at the source, wearing masks is a convenient and effective measure. In most cases, people use face masks in a high-frequent but short-time way. Aimed at solving the problem that we do not know which service stage of the mask belongs to, we propose a detection system based on the mobile phone. We first extract four features from the gray level co-occurrence matrixes (GLCMs) of the face mask's micro-photos. Next, a three-result detection system is accomplished by using K Nearest Neighbor (KNN) algorithm. The results of validation experiments show that our system can reach an accuracy of 82.87% (measured by macro-measures) on the testing dataset. The precision of Type I 'normal use' and the recall of type III 'not recommended' reach 92.00% and 92.59%. In future work, we plan to expand the detection objects to more mask types. This work demonstrates that the proposed mobile microscope system can be used as an assistant for face mask being used, which may play a positive role in fighting against COVID-19.
Collapse
Affiliation(s)
- Yuzhen Chen
- Shanghai Key Laboratory of Multidimensional Information Processing, School of Communication and Electronic EngineeringEast China Normal University Shanghai 200062 China
| | - Menghan Hu
- Shanghai Key Laboratory of Multidimensional Information Processing, School of Communication and Electronic EngineeringEast China Normal University Shanghai 200062 China
| | - Chunjun Hua
- Shanghai Key Laboratory of Multidimensional Information Processing, School of Communication and Electronic EngineeringEast China Normal University Shanghai 200062 China
| | - Guangtao Zhai
- Key Laboratory of Artificial IntelligenceMinistry of Education Shanghai 200240 China
| | - Jian Zhang
- Shanghai Key Laboratory of Multidimensional Information Processing, School of Communication and Electronic EngineeringEast China Normal University Shanghai 200062 China
| | - Qingli Li
- Shanghai Key Laboratory of Multidimensional Information Processing, School of Communication and Electronic EngineeringEast China Normal University Shanghai 200062 China
| | - Simon X Yang
- Advanced Robotics and Intelligent Systems Laboratory, School of EngineeringUniversity of Guelph Guelph ON N1G 2W1 Canada
| |
Collapse
|
35
|
Melo Costa M, Benoit N, Dormoi J, Amalvict R, Gomez N, Tissot-Dupont H, Million M, Pradines B, Granjeaud S, Almeras L. Salivette, a relevant saliva sampling device for SARS-CoV-2 detection. J Oral Microbiol 2021; 13:1920226. [PMID: 33986939 PMCID: PMC8098750 DOI: 10.1080/20002297.2021.1920226] [Citation(s) in RCA: 25] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2020] [Revised: 04/12/2021] [Accepted: 04/19/2021] [Indexed: 12/22/2022] Open
Abstract
Background: The gold standard for COVID-19 diagnosis relies on quantitative reverse-transcriptase polymerase-chain reaction (RT-qPCR) from nasopharyngeal swab (NPS) specimens, but NPSs present several limitations. The simplicity, low invasive and possibility of self-collection of saliva imposed these specimens as a relevant alternative for SARS-CoV-2 detection. However, the discrepancy of saliva test results compared to NPSs made of its use controversial. Here, we assessed Salivettes®, as a standardized saliva collection device, and compared SARS-CoV-2 positivity on paired NPS and saliva specimens. Methods: A total of 303 individuals randomly selected among those investigated for SARS-CoV-2 were enrolled, including 30 (9.9%) patients previously positively tested using NPS (follow-up group), 90 (29.7%) mildly symptomatic and 183 (60.4%) asymptomatic. Results: The RT-qPCR revealed a positive rate of 11.6% (n = 35) and 17.2% (n = 52) for NPSs and saliva samples, respectively. The sensitivity and specificity of saliva samples were 82.9% and 91.4%, respectively, using NPS as reference. The highest proportion of discordant results concerned the follow-up group (33.3%). Although the agreement exceeded 90.0% in the symptomatic and asymptomatic groups, 17 individuals were detected positive only in saliva samples, with consistent medical arguments. Conclusion Saliva collected with Salivette® was more sensitive for detecting symptomatic and pre-symptomatic infections.
Collapse
Affiliation(s)
- Monique Melo Costa
- Unité Parasitologie Et Entomologie, Département Microbiologie Et Maladies Infectieuses, Institut De Recherche Biomédicale Des Armées, Marseille, France
- Aix Marseille Univ, IRD, SSA, AP-HM, VITROME, Marseille, France
- IHU Méditerranée Infection, Marseille, France
| | - Nicolas Benoit
- Unité Parasitologie Et Entomologie, Département Microbiologie Et Maladies Infectieuses, Institut De Recherche Biomédicale Des Armées, Marseille, France
- Aix Marseille Univ, IRD, SSA, AP-HM, VITROME, Marseille, France
- IHU Méditerranée Infection, Marseille, France
- Centre National De Référence Du Paludisme, Marseille, France
| | - Jerome Dormoi
- Unité Parasitologie Et Entomologie, Département Microbiologie Et Maladies Infectieuses, Institut De Recherche Biomédicale Des Armées, Marseille, France
- Aix Marseille Univ, IRD, SSA, AP-HM, VITROME, Marseille, France
- IHU Méditerranée Infection, Marseille, France
| | - Remy Amalvict
- Unité Parasitologie Et Entomologie, Département Microbiologie Et Maladies Infectieuses, Institut De Recherche Biomédicale Des Armées, Marseille, France
- Aix Marseille Univ, IRD, SSA, AP-HM, VITROME, Marseille, France
- IHU Méditerranée Infection, Marseille, France
- Centre National De Référence Du Paludisme, Marseille, France
| | - Nicolas Gomez
- Unité Parasitologie Et Entomologie, Département Microbiologie Et Maladies Infectieuses, Institut De Recherche Biomédicale Des Armées, Marseille, France
- Aix Marseille Univ, IRD, SSA, AP-HM, VITROME, Marseille, France
- IHU Méditerranée Infection, Marseille, France
| | - Hervé Tissot-Dupont
- Aix Marseille Univ, IRD, SSA, AP-HM, VITROME, Marseille, France
- IHU Méditerranée Infection, Marseille, France
| | - Matthieu Million
- Aix Marseille Univ, IRD, SSA, AP-HM, VITROME, Marseille, France
- IHU Méditerranée Infection, Marseille, France
| | - Bruno Pradines
- Unité Parasitologie Et Entomologie, Département Microbiologie Et Maladies Infectieuses, Institut De Recherche Biomédicale Des Armées, Marseille, France
- Aix Marseille Univ, IRD, SSA, AP-HM, VITROME, Marseille, France
- IHU Méditerranée Infection, Marseille, France
- Centre National De Référence Du Paludisme, Marseille, France
| | - Samuel Granjeaud
- CRCM Integrative Bioinformatics Platform, Centre De Recherche En Cancérologie De Marseille, INSERM, U1068, Institut Paoli-Calmettes, CNRS, UMR7258, Aix-Marseille Université UM 105, Marseille, France
| | - Lionel Almeras
- Unité Parasitologie Et Entomologie, Département Microbiologie Et Maladies Infectieuses, Institut De Recherche Biomédicale Des Armées, Marseille, France
- Aix Marseille Univ, IRD, SSA, AP-HM, VITROME, Marseille, France
- IHU Méditerranée Infection, Marseille, France
| |
Collapse
|
36
|
Tushir S, Kamanna S, Nath SS, Bhat A, Rose S, Aithal AR, Tatu U. Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses. J Proteome Res 2021; 20:1591-1601. [PMID: 33555895 PMCID: PMC7885802 DOI: 10.1021/acs.jproteome.0c00808] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2020] [Indexed: 12/26/2022]
Abstract
A novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19) and continues to be a global health challenge. To understand viral disease biology, we have carried out proteo-genomic analysis using next-generation sequencing (NGS) and mass spectrometry on nasopharyngeal swabs of COVID-19 patients to examine the clinical genome and proteome. Our study confirms the mutability of SARS-CoV-2 showing multiple single-nucleotide polymorphisms. NGS analysis detected 27 mutations, of which 14 are synonymous, 11 are missense, and 2 are extragenic in nature. Phylogenetic analysis of SARS-CoV-2 isolates indicated their close relation to a Bangladesh isolate and multiple origins of isolates within the country. Our proteomic analysis, for the first time, identified 13 different SARS-CoV-2 proteins from the clinical swabs. Of the total 41 peptides captured by high-resolution mass spectrometry, 8 matched to nucleocapsid protein, 2 to ORF9b, and 1 to spike glycoprotein and ORF3a, with remaining peptides mapping to ORF1ab polyprotein. Additionally, host proteome analysis revealed several key host proteins to be uniquely expressed in COVID-19 patients. Pathway analysis of these proteins points toward modulation in immune response, especially involving neutrophil and IL-12-mediated signaling. Besides revealing the aspects of host-virus pathogenesis, our study opens new avenues to develop better diagnostic markers and therapeutic approaches.
Collapse
Affiliation(s)
- Sheetal Tushir
- Department of Biochemistry, Indian Institute
of Science, Bangalore 560012, India
| | - Sathisha Kamanna
- Department of Biochemistry, Indian Institute
of Science, Bangalore 560012, India
| | - Sujith S. Nath
- Department of Biochemistry, Indian Institute
of Science, Bangalore 560012, India
| | - Aishwarya Bhat
- Department of Biochemistry, Indian Institute
of Science, Bangalore 560012, India
| | - Steffimol Rose
- Department of Biochemistry, Indian Institute
of Science, Bangalore 560012, India
| | - Advait R. Aithal
- Department of Biochemistry, Indian Institute
of Science, Bangalore 560012, India
| | - Utpal Tatu
- Department of Biochemistry, Indian Institute
of Science, Bangalore 560012, India
| |
Collapse
|
37
|
Goud KY, Reddy KK, Khorshed A, Kumar VS, Mishra RK, Oraby M, Ibrahim AH, Kim H, Gobi KV. Electrochemical diagnostics of infectious viral diseases: Trends and challenges. Biosens Bioelectron 2021; 180:113112. [PMID: 33706158 PMCID: PMC7921732 DOI: 10.1016/j.bios.2021.113112] [Citation(s) in RCA: 44] [Impact Index Per Article: 14.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2021] [Revised: 02/06/2021] [Accepted: 02/22/2021] [Indexed: 02/07/2023]
Abstract
Infectious diseases caused by viruses can elevate up to undesired pandemic conditions affecting the global population and normal life function. These in turn impact the established world economy, create jobless situations, physical, mental, emotional stress, and challenge the human survival. Therefore, timely detection, treatment, isolation and prevention of spreading the pandemic infectious diseases not beyond the originated town is critical to avoid global impairment of life (e.g., Corona virus disease - 2019, COVID-19). The objective of this review article is to emphasize the recent advancements in the electrochemical diagnostics of twelve life-threatening viruses namely - COVID-19, Middle east respiratory syndrome (MERS), Severe acute respiratory syndrome (SARS), Influenza, Hepatitis, Human immunodeficiency virus (HIV), Human papilloma virus (HPV), Zika virus, Herpes simplex virus, Chikungunya, Dengue, and Rotavirus. This review describes the design, principle, underlying rationale, receptor, and mechanistic aspects of sensor systems reported for such viruses. Electrochemical sensor systems which comprised either antibody or aptamers or direct/mediated electron transfer in the recognition matrix were explicitly segregated into separate sub-sections for critical comparison. This review emphasizes the current challenges involved in translating laboratory research to real-world device applications, future prospects and commercialization aspects of electrochemical diagnostic devices for virus detection. The background and overall progress provided in this review are expected to be insightful to the researchers in sensor field and facilitate the design and fabrication of electrochemical sensors for life-threatening viruses with broader applicability to any desired pathogens.
Collapse
Affiliation(s)
- K Yugender Goud
- Department of NanoEngineering, University of California San Diego, La Jolla, CA, 92093, USA.
| | - K Koteshwara Reddy
- Smart Living Innovation Technology Centre, Department of Energy Science and Technology, Myongji University, Yongin, Gyeonggi-do, 17058, Republic of Korea.
| | - Ahmed Khorshed
- Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Sohag University, Sohag, 82524, Egypt.
| | - V Sunil Kumar
- Department of Chemistry, National Institute of Technology Warangal, Telangana, 506004, India
| | - Rupesh K Mishra
- Department of NanoEngineering, University of California San Diego, La Jolla, CA, 92093, USA
| | - Mohamed Oraby
- Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Sohag University, Sohag, 82524, Egypt
| | - Alyaa Hatem Ibrahim
- Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Sohag University, Sohag, 82524, Egypt
| | - Hern Kim
- Smart Living Innovation Technology Centre, Department of Energy Science and Technology, Myongji University, Yongin, Gyeonggi-do, 17058, Republic of Korea.
| | - K Vengatajalabathy Gobi
- Department of Chemistry, National Institute of Technology Warangal, Telangana, 506004, India.
| |
Collapse
|
38
|
Kabir MDA, Ahmed R, Iqbal SMA, Chowdhury R, Paulmurugan R, Demirci U, Asghar W. Diagnosis for COVID-19: current status and future prospects. Expert Rev Mol Diagn 2021; 21:269-288. [PMID: 33621145 PMCID: PMC7938658 DOI: 10.1080/14737159.2021.1894930] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2020] [Accepted: 02/22/2021] [Indexed: 01/08/2023]
Abstract
Introduction: Coronavirus disease 2019 (COVID-19), a respiratory illness caused by novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), had its first detection in December 2019 in Wuhan (China) and spread across the world. In March 2020, the World Health Organization (WHO) declared COVID-19 a pandemic disease. The utilization of prompt and accurate molecular diagnosis of SARS-CoV-2 virus, isolating the infected patients, and treating them are the keys to managing this unprecedented pandemic. International travel acted as a catalyst for the widespread transmission of the virus.Areas covered: This review discusses phenotype, structural, and molecular evolution of recognition elements and primers, its detection in the laboratory, and at point of care. Further, market analysis of commercial products and their performance are also evaluated, providing new ways to confront the ongoing global public health emergency.Expert commentary: The outbreak for COVID-19 created mammoth chaos in the healthcare sector, and still, day by day, new epicenters for the outbreak are being reported. Emphasis should be placed on developing more effective, rapid, and early diagnostic devices. The testing laboratories should invest more in clinically relevant multiplexed and scalable detection tools to fight against a pandemic like this where massive demand for testing exists.
Collapse
Affiliation(s)
- MD Alamgir Kabir
- Florida Atlantic University, Boca Raton, FL, USA
- College of Engineering and Computer Science, Boca Raton, FL, USA
| | - Rajib Ahmed
- Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford School of Medicine, Palo Alto, CA, USA
| | - Sheikh Muhammad Asher Iqbal
- Florida Atlantic University, Boca Raton, FL, USA
- College of Engineering and Computer Science, Boca Raton, FL, USA
| | | | - Ramasamy Paulmurugan
- Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford School of Medicine, Palo Alto, CA, USA
| | - Utkan Demirci
- Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford School of Medicine, Palo Alto, CA, USA
| | - Waseem Asghar
- Florida Atlantic University, Boca Raton, FL, USA
- College of Engineering and Computer Science, Boca Raton, FL, USA
- Department of Biological Sciences (Courtesy Appointment, Florida Atlantic University, Boca Raton, FL, USA
| |
Collapse
|
39
|
Sharma S, Saini S, Khangembam M, Singh V. Nanomaterials-Based Biosensors for COVID-19 Detection-A Review. IEEE SENSORS JOURNAL 2021; 21:5598-5611. [PMID: 37974905 PMCID: PMC8768986 DOI: 10.1109/jsen.2020.3036748] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/19/2020] [Revised: 10/31/2020] [Accepted: 11/03/2020] [Indexed: 11/19/2023]
Abstract
This review paper discusses the properties of nanomaterials, namely graphene, molybdenum disulfide, carbon nanotubes, and quantum dots for unique sensing applications. Based on the specific analyte to be detected and the functionalization techniques that are employed, some noteworthy sensors that have been developed are discussed. Further, biocompatible sensors fabricated from these materials capable of detecting specific chemical compounds are also highlighted for COVID-19 detection purposes, which can aid in efficient and reliable sensing as well as timely diagnosis.
Collapse
Affiliation(s)
- Sakshi Sharma
- Department of Applied PhysicsDelhi Technological UniversityNew Delhi110042India
| | - Sonakshi Saini
- Department of Applied PhysicsDelhi Technological UniversityNew Delhi110042India
| | - Maya Khangembam
- Department of Applied PhysicsDelhi Technological UniversityNew Delhi110042India
| | - Vinod Singh
- Department of Applied PhysicsDelhi Technological UniversityNew Delhi110042India
| |
Collapse
|
40
|
Microbial Electrochemical Systems: Principles, Construction and Biosensing Applications. SENSORS 2021; 21:s21041279. [PMID: 33670122 PMCID: PMC7916843 DOI: 10.3390/s21041279] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/13/2021] [Revised: 02/02/2021] [Accepted: 02/04/2021] [Indexed: 02/07/2023]
Abstract
Microbial electrochemical systems are a fast emerging technology that use microorganisms to harvest the chemical energy from bioorganic materials to produce electrical power. Due to their flexibility and the wide variety of materials that can be used as a source, these devices show promise for applications in many fields including energy, environment and sensing. Microbial electrochemical systems rely on the integration of microbial cells, bioelectrochemistry, material science and electrochemical technologies to achieve effective conversion of the chemical energy stored in organic materials into electrical power. Therefore, the interaction between microorganisms and electrodes and their operation at physiological important potentials are critical for their development. This article provides an overview of the principles and applications of microbial electrochemical systems, their development status and potential for implementation in the biosensing field. It also provides a discussion of the recent developments in the selection of electrode materials to improve electron transfer using nanomaterials along with challenges for achieving practical implementation, and examples of applications in the biosensing field.
Collapse
|
41
|
Gowri A, Ashwin Kumar N, Suresh Anand BS. Recent advances in nanomaterials based biosensors for point of care (PoC) diagnosis of Covid-19 - A minireview. Trends Analyt Chem 2021; 137:116205. [PMID: 33531721 PMCID: PMC7842193 DOI: 10.1016/j.trac.2021.116205] [Citation(s) in RCA: 55] [Impact Index Per Article: 18.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Early diagnosis and ultrahigh sample throughput screening are the need of the hour to control the geological spread of the COVID-19 pandemic. Traditional laboratory tests such as enzyme-linked immunosorbent assay (ELISA), reverse transcription polymerase chain reaction (RT-PCR) and computed tomography are implemented for the detection of COVID-19. However, they are limited by the laborious sample collection and processing procedures, longer wait time for test results and skilled technicians to operate sophisticated facilities. In this context, the point of care (PoC) diagnostic platform has proven to be the prospective approach in addressing the abovementioned challenges. This review emphasizes the mechanism of viral infection spread detailing the host-virus interaction, pathophysiology, and the recent advances in the development of affordable PoC diagnostic platforms for rapid and accurate diagnosis of COVID-19. First, the well-established optical and electrochemical biosensors are discussed. Subsequently, the recent advances in the development of PoC biosensors, including lateral flow immunoassays and other emerging techniques, are highlighted. Finally, a focus on integrating nanotechnology with wearables and smartphones to develop smart nanobiosensors is outlined, which could promote COVID-19 diagnosis accessible to both individuals and the mass population at patient care.
Collapse
Affiliation(s)
- Annasamy Gowri
- Department of Biomedical Engineering, Vel Tech Research Park, Vel Tech Rangarajan Dr.Sagunthala R & D Institute of Science and Technology, Avadi, Chennai 600 062, Tamil Nadu, India
| | - N Ashwin Kumar
- Department of Biomedical Engineering, SRM Institute of Science and Technology, SRM Nagar, Kattankulathur 603203, Tamil Nadu, India
| | - B S Suresh Anand
- Department of Biomedical Engineering, Rajalakshmi Engineering College, Thandalam, Chennai 602 105, Tamil Nadu, India
| |
Collapse
|
42
|
Eftekhari A, Alipour M, Chodari L, Maleki Dizaj S, Ardalan M, Samiei M, Sharifi S, Zununi Vahed S, Huseynova I, Khalilov R, Ahmadian E, Cucchiarini M. A Comprehensive Review of Detection Methods for SARS-CoV-2. Microorganisms 2021; 9:232. [PMID: 33499379 PMCID: PMC7911200 DOI: 10.3390/microorganisms9020232] [Citation(s) in RCA: 64] [Impact Index Per Article: 21.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2020] [Revised: 01/11/2021] [Accepted: 01/16/2021] [Indexed: 12/14/2022] Open
Abstract
Recently, the outbreak of the coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, in China and its subsequent spread across the world has caused numerous infections and deaths and disrupted normal social activity. Presently, various techniques are used for the diagnosis of SARS-CoV-2 infection, with various advantages and weaknesses to each. In this paper, we summarize promising methods, such as reverse transcription-polymerase chain reaction (RT-PCR), serological testing, point-of-care testing, smartphone surveillance of infectious diseases, nanotechnology-based approaches, biosensors, amplicon-based metagenomic sequencing, smartphone, and wastewater-based epidemiology (WBE) that can also be utilized for the detection of SARS-CoV-2. In addition, we discuss principles, advantages, and disadvantages of these detection methods, and highlight the potential methods for the development of additional techniques and products for early and fast detection of SARS-CoV-2.
Collapse
Affiliation(s)
- Aziz Eftekhari
- Pharmacology and Toxicology Department, Maragheh University of Medical Sciences, Maragheh 5515878151, Iran;
| | - Mahdieh Alipour
- Dental and Periodontal Research Center, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz 5166615731, Iran; (M.A.); (S.M.D.); (S.S.)
| | - Leila Chodari
- Physiology Department, Faculty of Medicine, Urmia University of Medical Sciences, Urmia 571478334, Iran;
| | - Solmaz Maleki Dizaj
- Dental and Periodontal Research Center, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz 5166615731, Iran; (M.A.); (S.M.D.); (S.S.)
| | - Mohammadreza Ardalan
- Kidney Research Center, Imam Reza Hospital, Tabriz University of Medical Sciences, Tabriz 5166615731, Iran; (M.A.); (S.Z.V.)
| | - Mohammad Samiei
- Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz 5166615731, Iran;
| | - Simin Sharifi
- Dental and Periodontal Research Center, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz 5166615731, Iran; (M.A.); (S.M.D.); (S.S.)
| | - Sepideh Zununi Vahed
- Kidney Research Center, Imam Reza Hospital, Tabriz University of Medical Sciences, Tabriz 5166615731, Iran; (M.A.); (S.Z.V.)
| | - Irada Huseynova
- Institute of Molecular Biology & Biotechnologies, Azerbaijan National Academy of Sciences, 11 Izzat Nabiyev, Baku AZ 1073, Azerbaijan;
| | - Rovshan Khalilov
- Department of Biophysics and Biochemistry, Baku State University, Baku AZ 1148, Azerbaijan;
- Joint Ukraine-Azerbaijan International Research and Education Center of Nanobiotechnology and Functional Nanosystems, 82100 Drohobych, Ukraine
| | - Elham Ahmadian
- Kidney Research Center, Imam Reza Hospital, Tabriz University of Medical Sciences, Tabriz 5166615731, Iran; (M.A.); (S.Z.V.)
| | - Magali Cucchiarini
- Center of Experimental Orthopaedics, Saarland University Medical Center, D-66421 Homburg/Saar, Germany
| |
Collapse
|
43
|
Abstract
Analytical devices for point-of-care diagnoses are highly desired and would improve quality of life when first diagnoses are made early and pathologies are recognized soon. Lateral flow tests (LFTs) are such tools that can be easily performed without specific equipment, skills, or experiences. This review is focused on the use of LFT in point-of-care diagnoses. The principle of the assay is explained, and new materials like nanoparticles for labeling, new recognition molecules for interaction with an analyte, and new additional instrumentation like signal scaling by a smartphone camera are described and discussed. Advantages of the LFT devices as well as their limitations are described and discussed here considering actual papers that are properly cited.
Collapse
|
44
|
Abstract
The emergence and spread of infectious diseases with pandemic potential occurred regularly throughout history. Major pandemics and epidemics such as plague, cholera, flu, severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) have already afflicted humanity. The world is now facing the new coronavirus disease 2019 (COVID-19) pandemic. Many infectious diseases leading to pandemics are caused by zoonotic pathogens that were transmitted to humans due to increased contacts with animals through breeding, hunting and global trade activities. The understanding of the mechanisms of transmission of pathogens to humans allowed the establishment of methods to prevent and control infections. During centuries, implementation of public health measures such as isolation, quarantine and border control helped to contain the spread of infectious diseases and maintain the structure of the society. In the absence of pharmaceutical interventions, these containment methods have still been used nowadays to control COVID-19 pandemic. Global surveillance programs of water-borne pathogens, vector-borne diseases and zoonotic spillovers at the animal-human interface are of prime importance to rapidly detect the emergence of infectious threats. Novel technologies for rapid diagnostic testing, contact tracing, drug repurposing, biomarkers of disease severity as well as new platforms for the development and production of vaccines are needed for an effective response in case of pandemics.
Collapse
Affiliation(s)
- Jocelyne Piret
- CHU de Québec - Laval University, Quebec City, QC, Canada
| | - Guy Boivin
- CHU de Québec - Laval University, Quebec City, QC, Canada
| |
Collapse
|
45
|
Rasmi Y, Li X, Khan J, Ozer T, Choi JR. Emerging point-of-care biosensors for rapid diagnosis of COVID-19: current progress, challenges, and future prospects. Anal Bioanal Chem 2021; 413:4137-4159. [PMID: 34008124 PMCID: PMC8130795 DOI: 10.1007/s00216-021-03377-6] [Citation(s) in RCA: 47] [Impact Index Per Article: 15.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2021] [Accepted: 04/26/2021] [Indexed: 02/07/2023]
Abstract
Coronavirus disease 2019 (COVID-19) pandemic is currently a serious global health threat. While conventional laboratory tests such as quantitative real-time polymerase chain reaction (qPCR), serology tests, and chest computerized tomography (CT) scan allow diagnosis of COVID-19, these tests are time-consuming and laborious, and are limited in resource-limited settings or developing countries. Point-of-care (POC) biosensors such as chip-based and paper-based biosensors are typically rapid, portable, cost-effective, and user-friendly, which can be used for COVID-19 in remote settings. The escalating demand for rapid diagnosis of COVID-19 presents a strong need for a timely and comprehensive review on the POC biosensors for COVID-19 that meet ASSURED criteria: Affordable, Sensitive, Specific, User-friendly, Rapid and Robust, Equipment-free, and Deliverable to end users. In the present review, we discuss the importance of rapid and early diagnosis of COVID-19 and pathogenesis of COVID-19 along with the key diagnostic biomarkers. We critically review the most recent advances in POC biosensors which show great promise for the detection of COVID-19 based on three main categories: chip-based biosensors, paper-based biosensors, and other biosensors. We subsequently discuss the key benefits of these biosensors and their use for the detection of antigen, antibody, and viral nucleic acids. The commercial POC biosensors for COVID-19 are critically compared. Finally, we discuss the key challenges and future perspectives of developing emerging POC biosensors for COVID-19. This review would be very useful for guiding strategies for developing and commercializing rapid POC tests to manage the spread of infections.Graphical abstract.
Collapse
Affiliation(s)
- Yousef Rasmi
- Department of Biochemistry, Faculty of Medicine, Urmia University of Medical Sciences, 5714783734, Urmia, Iran ,Cellular and Molecular Research Center, Urmia University of Medical Sciences, 5714783734, Urmia, Iran
| | - Xiaokang Li
- Ludwig Institute for Cancer Research, University of Lausanne, Agora Center, 1005 Lausanne, Switzerland ,Department of Oncology, Centre hospitalier universitaire vaudois (CHUV), 1011 Lausanne, Switzerland
| | - Johra Khan
- Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Majmaah, 11952 Kingdom of Saudi Arabia
| | - Tugba Ozer
- Department of Bioengineering, Faculty of Chemical-Metallurgical Engineering, Yildiz Technical University, 34220 Istanbul, Turkey
| | - Jane Ru Choi
- Department of Mechanical Engineering, University of British Columbia, Vancouver, BC V6T 1Z4 Canada ,Centre for Blood Research, Life Sciences Centre, University of British Columbia, Vancouver, BC V6T 1Z3 Canada
| |
Collapse
|
46
|
Nemčeková K, Labuda J. Advanced materials-integrated electrochemical sensors as promising medical diagnostics tools: A review. MATERIALS SCIENCE & ENGINEERING. C, MATERIALS FOR BIOLOGICAL APPLICATIONS 2020; 120:111751. [PMID: 33545892 DOI: 10.1016/j.msec.2020.111751] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/15/2020] [Revised: 11/13/2020] [Accepted: 11/21/2020] [Indexed: 02/08/2023]
Abstract
Electrochemical sensors have increasingly been linked with terms as modern biomedically effective highly selective and sensitive devices, wearable and wireless technology, portable electronics, smart textiles, energy storage, communication and user-friendly operating systems. The work brings the overview of the current advanced materials and their application strategies for improving performance, miniaturization and portability of sensing devices. It provides the extensive information on recently developed (bio)sensing platforms based on voltammetric, amperometric, potentiometric and impedimetric detection modes including portable, non-invasive, wireless, and self-driven miniaturized devices for monitoring human and animal health. Diagnostics of selected free radical precursors, low molecular biomarkers, nucleic acids and protein-based biomarkers, bacteria and viruses of today's interest is demonstrated.
Collapse
Affiliation(s)
- Katarína Nemčeková
- Institute of Analytical Chemistry, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Bratislava 81237, Slovakia.
| | - Ján Labuda
- Institute of Analytical Chemistry, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Bratislava 81237, Slovakia.
| |
Collapse
|